{"title":"Asthma Care","description":null,"products":[{"product_id":"deliresp","title":"Deliresp","description":"\u003ch3 data-start=\"343\" data-end=\"369\"\u003eWhat is Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"370\" data-end=\"750\"\u003e\u003cstrong data-start=\"370\" data-end=\"385\"\u003eRoflumilast\u003c\/strong\u003e is an oral, selective phosphodiesterase‑4 (PDE4) inhibitor approved for use as a maintenance treatment in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations. It works by reducing airway inflammation, thereby improving lung function and decreasing the frequency of COPD exacerbations.\u003c\/p\u003e\r\n\u003cp data-start=\"752\" data-end=\"903\"\u003e\u003cem data-start=\"752\" data-end=\"903\"\u003eReference: U.S. Food and Drug Administration (FDA) Roflumilast Prescribing Information; World Health Organization (WHO) guidelines on COPD management\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"905\" data-end=\"908\"\u003e\r\n\u003ch3 data-start=\"910\" data-end=\"965\"\u003eWhat are the other popular names for Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"966\" data-end=\"1029\"\u003eRoflumilast is marketed under several brand names, including:\u003c\/p\u003e\r\n\u003cul data-start=\"1030\" data-end=\"1130\"\u003e\r\n\u003cli data-start=\"1030\" data-end=\"1082\"\u003e\n\u003cstrong data-start=\"1032\" data-end=\"1045\"\u003eDaliresp®\u003c\/strong\u003e (widely used in the United States)\u003c\/li\u003e\r\n\u003cli data-start=\"1083\" data-end=\"1130\"\u003e\n\u003cstrong data-start=\"1085\" data-end=\"1096\"\u003eAriflo®\u003c\/strong\u003e (in some international markets)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"1132\" data-end=\"1173\"\u003e\u003cem data-start=\"1132\" data-end=\"1173\"\u003eReference: U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1175\" data-end=\"1178\"\u003e\r\n\u003ch3 data-start=\"1180\" data-end=\"1233\"\u003eWhat is the drug classification of Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1234\" data-end=\"1443\"\u003eRoflumilast is classified as an \u003cstrong data-start=\"1266\" data-end=\"1299\"\u003eoral selective PDE4 inhibitor\u003c\/strong\u003e. It falls under the therapeutic category of \u003cstrong data-start=\"1344\" data-end=\"1397\"\u003eanti-inflammatory agents for respiratory diseases\u003c\/strong\u003e, specifically used in the management of COPD.\u003c\/p\u003e\r\n\u003cp data-start=\"1445\" data-end=\"1499\"\u003e\u003cem data-start=\"1445\" data-end=\"1499\"\u003eReference: U.S. FDA; World Health Organization (WHO)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1501\" data-end=\"1504\"\u003e\r\n\u003ch3 data-start=\"1506\" data-end=\"1554\"\u003eWhat is the mode of action of Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1555\" data-end=\"1751\"\u003eRoflumilast works by inhibiting the enzyme phosphodiesterase‑4 (PDE4) in inflammatory cells. This inhibition increases intracellular cyclic adenosine monophosphate (cAMP) levels, which leads to:\u003c\/p\u003e\r\n\u003cul data-start=\"1752\" data-end=\"1987\"\u003e\r\n\u003cli data-start=\"1752\" data-end=\"1868\"\u003e\n\u003cstrong data-start=\"1754\" data-end=\"1804\"\u003eReduced Release of Pro-inflammatory Mediators:\u003c\/strong\u003e Lowering cytokine production and inflammation in the airways.\u003c\/li\u003e\r\n\u003cli data-start=\"1869\" data-end=\"1987\"\u003e\n\u003cstrong data-start=\"1871\" data-end=\"1892\"\u003eImproved Airflow:\u003c\/strong\u003e By reducing inflammation, it helps alleviate bronchoconstriction and improves lung function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"1989\" data-end=\"2061\"\u003e\u003cem data-start=\"1989\" data-end=\"2061\"\u003eReference: PubMed (e.g., studies on PDE4 inhibition in COPD); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2063\" data-end=\"2066\"\u003e\r\n\u003ch3 data-start=\"2068\" data-end=\"2098\"\u003eHow is Roflumilast used?\u003c\/h3\u003e\r\n\u003cp data-start=\"2099\" data-end=\"2405\"\u003eRoflumilast is used as a \u003cstrong data-start=\"2124\" data-end=\"2149\"\u003emaintenance treatment\u003c\/strong\u003e in patients with severe COPD, particularly in those with chronic bronchitis who are prone to frequent exacerbations. It is intended for long‑term use as part of a comprehensive treatment plan that may also include bronchodilators and other COPD therapies.\u003c\/p\u003e\r\n\u003cp data-start=\"2407\" data-end=\"2492\"\u003e\u003cem data-start=\"2407\" data-end=\"2492\"\u003eReference: American Thoracic Society (ATS) guidelines; U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2494\" data-end=\"2497\"\u003e\r\n\u003ch3 data-start=\"2499\" data-end=\"2571\"\u003eWhat is the recommended dosage and administration for Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"2572\" data-end=\"2886\"\u003e\r\n\u003cli data-start=\"2572\" data-end=\"2647\"\u003e\n\u003cstrong data-start=\"2574\" data-end=\"2585\"\u003eDosage:\u003c\/strong\u003e The typical recommended oral dose is \u003cstrong data-start=\"2623\" data-end=\"2644\"\u003e500 µg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2648\" data-end=\"2886\"\u003e\n\u003cstrong data-start=\"2650\" data-end=\"2669\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2674\" data-end=\"2886\"\u003e\r\n\u003cli data-start=\"2674\" data-end=\"2777\"\u003eRoflumilast should be taken once daily, with or without food, preferably at the same time each day.\u003c\/li\u003e\r\n\u003cli data-start=\"2780\" data-end=\"2886\"\u003eConsistent use is key to maintaining its anti‑inflammatory effect and improving lung function over time.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2888\" data-end=\"2965\"\u003e\u003cem data-start=\"2888\" data-end=\"2965\"\u003eReference: U.S. FDA Roflumilast Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2967\" data-end=\"2970\"\u003e\r\n\u003ch3 data-start=\"2972\" data-end=\"3036\"\u003eWhat prescribing information is important for Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3037\" data-end=\"3730\"\u003e\r\n\u003cli data-start=\"3037\" data-end=\"3197\"\u003e\n\u003cstrong data-start=\"3039\" data-end=\"3055\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3060\" data-end=\"3197\"\u003e\r\n\u003cli data-start=\"3060\" data-end=\"3197\"\u003eRoflumilast is indicated for reducing the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3198\" data-end=\"3408\"\u003e\n\u003cstrong data-start=\"3200\" data-end=\"3222\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3227\" data-end=\"3408\"\u003e\r\n\u003cli data-start=\"3227\" data-end=\"3294\"\u003eKnown hypersensitivity to roflumilast or any of its components.\u003c\/li\u003e\r\n\u003cli data-start=\"3297\" data-end=\"3408\"\u003eNot recommended for use in patients with moderate to severe liver impairment without careful consideration.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3409\" data-end=\"3539\"\u003e\n\u003cstrong data-start=\"3411\" data-end=\"3426\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3431\" data-end=\"3539\"\u003e\r\n\u003cli data-start=\"3431\" data-end=\"3539\"\u003ePatients should have periodic liver function tests and assessments for potential psychiatric side effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3540\" data-end=\"3730\"\u003e\n\u003cstrong data-start=\"3542\" data-end=\"3569\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3574\" data-end=\"3730\"\u003e\r\n\u003cli data-start=\"3574\" data-end=\"3653\"\u003eRoflumilast should be used as part of a comprehensive COPD management plan.\u003c\/li\u003e\r\n\u003cli data-start=\"3656\" data-end=\"3730\"\u003eThe drug is not intended for the immediate relief of acute bronchospasm.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3732\" data-end=\"3806\"\u003e\u003cem data-start=\"3732\" data-end=\"3806\"\u003eReference: U.S. FDA; WHO; National Institutes of Health (NIH) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3808\" data-end=\"3811\"\u003e\r\n\u003ch3 data-start=\"3813\" data-end=\"3899\"\u003eWhat safety information, warnings, and cautions are associated with Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3900\" data-end=\"4672\"\u003e\r\n\u003cli data-start=\"3900\" data-end=\"3987\"\u003e\n\u003cstrong data-start=\"3902\" data-end=\"3926\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3931\" data-end=\"3987\"\u003e\r\n\u003cli data-start=\"3931\" data-end=\"3987\"\u003eDiarrhea, weight loss, nausea, headache, and insomnia.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3988\" data-end=\"4672\"\u003e\n\u003cstrong data-start=\"3990\" data-end=\"4014\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4019\" data-end=\"4672\"\u003e\r\n\u003cli data-start=\"4019\" data-end=\"4180\"\u003e\n\u003cstrong data-start=\"4021\" data-end=\"4045\"\u003ePsychiatric Effects:\u003c\/strong\u003e Roflumilast may be associated with mood changes, anxiety, or depression in some patients. Monitor for signs of psychiatric distress.\u003c\/li\u003e\r\n\u003cli data-start=\"4183\" data-end=\"4323\"\u003e\n\u003cstrong data-start=\"4185\" data-end=\"4214\"\u003eGastrointestinal Effects:\u003c\/strong\u003e Diarrhea and weight loss can occur; patients should be advised to maintain proper hydration and nutrition.\u003c\/li\u003e\r\n\u003cli data-start=\"4326\" data-end=\"4501\"\u003e\n\u003cstrong data-start=\"4328\" data-end=\"4349\"\u003eHepatic Function:\u003c\/strong\u003e There is a risk of liver enzyme elevation; liver function should be monitored periodically, especially in patients with preexisting liver conditions.\u003c\/li\u003e\r\n\u003cli data-start=\"4504\" data-end=\"4672\"\u003e\n\u003cstrong data-start=\"4506\" data-end=\"4541\"\u003eContraindications in Pregnancy:\u003c\/strong\u003e Roflumilast is contraindicated during pregnancy and lactation. Women of childbearing potential should use effective contraception.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4674\" data-end=\"4774\"\u003e\u003cem data-start=\"4674\" data-end=\"4774\"\u003eReference: U.S. FDA Roflumilast Prescribing Information; PubMed literature on PDE4 inhibitors; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4776\" data-end=\"4779\"\u003e\r\n\u003ch3 data-start=\"4781\" data-end=\"4848\"\u003eWhat drug interactions should be considered with Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"4849\" data-end=\"5364\"\u003e\r\n\u003cli data-start=\"4849\" data-end=\"5067\"\u003e\n\u003cstrong data-start=\"4851\" data-end=\"4873\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"4878\" data-end=\"5067\"\u003e\r\n\u003cli data-start=\"4878\" data-end=\"5067\"\u003eConcomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase plasma levels of roflumilast and its active metabolite, potentially enhancing adverse effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5068\" data-end=\"5222\"\u003e\n\u003cstrong data-start=\"5070\" data-end=\"5122\"\u003eOther Medications with Gastrointestinal Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"5127\" data-end=\"5222\"\u003e\r\n\u003cli data-start=\"5127\" data-end=\"5222\"\u003eDrugs that cause gastrointestinal upset may have additive effects when used with roflumilast.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5223\" data-end=\"5364\"\u003e\n\u003cstrong data-start=\"5225\" data-end=\"5248\"\u003eHepatotoxic Agents:\u003c\/strong\u003e\r\n\u003cul data-start=\"5253\" data-end=\"5364\"\u003e\r\n\u003cli data-start=\"5253\" data-end=\"5364\"\u003eCaution is advised when roflumilast is used in patients receiving medications that can impair liver function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5366\" data-end=\"5428\"\u003e\u003cem data-start=\"5366\" data-end=\"5428\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5430\" data-end=\"5433\"\u003e\r\n\u003ch3 data-start=\"5435\" data-end=\"5530\"\u003eWhere can I find additional clinical evidence and detailed information about Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"5531\" data-end=\"5621\"\u003eFor further details on clinical studies, dosing, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"5622\" data-end=\"5930\"\u003e\r\n\u003cli data-start=\"5622\" data-end=\"5710\"\u003e\n\u003cstrong data-start=\"5624\" data-end=\"5676\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"5677\" data-end=\"5708\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"5711\" data-end=\"5789\"\u003e\n\u003cstrong data-start=\"5713\" data-end=\"5736\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for roflumilast studies (e.g., NCT00910696)\u003c\/li\u003e\r\n\u003cli data-start=\"5790\" data-end=\"5857\"\u003e\n\u003cstrong data-start=\"5792\" data-end=\"5828\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e COPD management guidelines\u003c\/li\u003e\r\n\u003cli data-start=\"5858\" data-end=\"5930\"\u003e\n\u003cstrong data-start=\"5860\" data-end=\"5871\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on roflumilast in COPD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5932\" data-end=\"5966\"\u003e\u003cem data-start=\"5932\" data-end=\"5966\"\u003eReference: U.S. FDA; WHO; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5968\" data-end=\"5971\"\u003e\r\n\u003ch3 data-start=\"5973\" data-end=\"5993\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"5994\" data-end=\"6605\"\u003e\u003cstrong data-start=\"5994\" data-end=\"6009\"\u003eRoflumilast\u003c\/strong\u003e is an effective oral PDE4 inhibitor used to reduce the frequency of COPD exacerbations in patients with severe COPD and chronic bronchitis. By increasing cAMP levels in inflammatory cells, it diminishes airway inflammation and improves lung function. Due to its potential gastrointestinal and psychiatric side effects—and its interactions with certain CYP3A4 inhibitors—roflumilast should be prescribed with careful patient selection and monitoring. Always consult your healthcare provider to determine if roflumilast is the appropriate treatment as part of a comprehensive COPD management plan.\u003c\/p\u003e\r\n\u003cp data-start=\"6607\" data-end=\"6831\"\u003e\u003cem data-start=\"6607\" data-end=\"6831\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"500mcg","offer_id":51735705190683,"sku":"Generic-Deliresp-(Roflumilast)-Rofum-1-1","price":35.4,"currency_code":"USD","in_stock":true}]},{"product_id":"salbutamol","title":"SALBUTAMOL","description":"\u003ch4\u003eWhat is  SALBUTAMOL     ?\u003c\/h4\u003e\u003cp\u003e SALBUTAMOL      is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"2mg","offer_id":51735705223451,"sku":"SALBUTAMOL2mg","price":9.07,"currency_code":"USD","in_stock":true},{"title":"4mg","offer_id":51735705256219,"sku":"SALBUTAMOL4mg","price":10.58,"currency_code":"USD","in_stock":true},{"title":"8mg","offer_id":51735705288987,"sku":"SALBUTAMOL8mg","price":14.11,"currency_code":"USD","in_stock":true}]},{"product_id":"bricanyl","title":"Bricanyl","description":"\u003ch4\u003eWhat is Bricanyl ?\u003c\/h4\u003e\u003cp\u003eBricanyl  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"2.5mg","offer_id":51735705321755,"sku":"Bricanyl2.5mg","price":32.88,"currency_code":"USD","in_stock":true},{"title":"5mg","offer_id":51735705354523,"sku":"Bricanyl5mg","price":43.78,"currency_code":"USD","in_stock":true}]},{"product_id":"ventolin-inhaler","title":"VENTOLIN INHALER","description":"\u003ch4\u003eWhat is  VENTOLIN INHALER ?\u003c\/h4\u003e\u003cp\u003e VENTOLIN INHALER  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"100mcg\/200mdi","offer_id":51735705387291,"sku":"VENTOLININHALER100mcg\/200mdi","price":7.58,"currency_code":"USD","in_stock":true}]},{"product_id":"qvar-inhaler-mdi","title":"QVAR INHALER  MDI","description":"\u003ch4\u003eWhat is  QVAR INHALER  MDI?\u003c\/h4\u003e\u003cp\u003e QVAR INHALER  MDI is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"100\/200","offer_id":51735705420059,"sku":"QVARINHALER100\/200MDI","price":50.69,"currency_code":"USD","in_stock":true},{"title":"50\/200","offer_id":51735705452827,"sku":"QVARINHALER50\/200MDI","price":21.6,"currency_code":"USD","in_stock":true}]},{"product_id":"pulmicort-inhaler","title":"PULMICORT INHALER","description":"\u003ch4\u003eWhat is  PULMICORT INHALER ?\u003c\/h4\u003e\u003cp\u003e PULMICORT INHALER  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"100mcg\/200mdi","offer_id":51735705485595,"sku":"PULMICORTINHALER100mcg\/200mdi","price":42.07,"currency_code":"USD","in_stock":true},{"title":"200mcg\/200mdi","offer_id":51735705518363,"sku":"PULMICORTINHALER200mcg\/200mdi","price":53.35,"currency_code":"USD","in_stock":true}]},{"product_id":"pulmicort-rotacaps-200mcg","title":"PULMICORT ROTACAPS 200mcg","description":"\u003ch4\u003eWhat is  PULMICORT ROTACAPS 200mcg?\u003c\/h4\u003e\u003cp\u003e PULMICORT ROTACAPS 200mcg is a capsule supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735705551131,"sku":"PULMICORTROTACAPS200mcg","price":12.04,"currency_code":"USD","in_stock":true}]},{"product_id":"advair-rotacaps-100-50mcg","title":"ADVAIR ROTACAPS 100\/50mcg","description":"\u003ch4\u003eWhat is  ADVAIR ROTACAPS 100\/50mcg?\u003c\/h4\u003e\u003cp\u003e ADVAIR ROTACAPS 100\/50mcg is a capsule supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735705583899,"sku":"ADVAIRROTACAPS100\/50mcg","price":17.41,"currency_code":"USD","in_stock":true}]},{"product_id":"advair-inhaler","title":"ADVAIR INHALER","description":"\u003ch4\u003eWhat is  ADVAIR INHALER ?\u003c\/h4\u003e\u003cp\u003e ADVAIR INHALER  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"250\/25mcg\/120mdi","offer_id":51735705616667,"sku":"ADVAIRINHALER250\/25mcg\/120mdi","price":28.3,"currency_code":"USD","in_stock":true},{"title":"50\/25mcg\/120mdi","offer_id":51735705649435,"sku":"ADVAIRINHALER50\/25mcg\/120mdi","price":18.76,"currency_code":"USD","in_stock":true},{"title":"125\/25mcg\/120mdi","offer_id":51735705682203,"sku":"ADVAIRINHALER125\/25mcg\/120mdi","price":20.54,"currency_code":"USD","in_stock":true},{"title":"250\/50mcg","offer_id":51735705714971,"sku":"ADVAIRInhaler250\/50mcg","price":23.46,"currency_code":"USD","in_stock":true},{"title":"500\/50mcg\/120mdi","offer_id":51735705747739,"sku":"ADVAIRINHALER500\/50mcg\/120mdi","price":23.21,"currency_code":"USD","in_stock":true}]},{"product_id":"advair-500-50mcg","title":"Advair 500\/50mcg","description":"\u003ch4\u003eWhat is  Advair 500\/50mcg?\u003c\/h4\u003e\u003cp\u003e Advair 500\/50mcg is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735705780507,"sku":"Advair500\/50mcg","price":18.6,"currency_code":"USD","in_stock":true}]},{"product_id":"xopenex-inhaler","title":"XOPENEX INHALER","description":"\u003cp\u003e\u003cstrong\u003e1. What is Levalbuterol Inhaler and what is it used for?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol Inhaler is a prescription medication classified as a short-acting beta-agonist (SABA). It is primarily used to treat or prevent bronchospasms in individuals with reversible obstructive airway disease, such as asthma or chronic obstructive pulmonary disease (COPD). It is also used to prevent exercise-induced bronchospasms.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e2. What is the active ingredient in Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eThe active ingredient in this inhaler is \u003cstrong\u003eLevalbuterol Hydrochloride\u003c\/strong\u003e. It works by relaxing the muscles in the airways, improving airflow and making it easier to breathe.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e3. How does Levalbuterol Inhaler work?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol binds to beta-2 adrenergic receptors in the airway smooth muscle. This action triggers the relaxation of the muscles, reducing airway constriction, and alleviating symptoms like wheezing, shortness of breath, and chest tightness.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e4. Who can use Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol Inhaler is approved for use in both adults and children aged \u003cstrong\u003e4 years and older\u003c\/strong\u003e. However, its use should be guided by a healthcare provider, especially in children or patients with pre-existing medical conditions.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e5. How should Levalbuterol Inhaler be used?\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eFor bronchospasm treatment:\u003c\/strong\u003e Take \u003cstrong\u003e2 inhalations every 4 to 6 hours\u003c\/strong\u003e, as needed.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eFor exercise-induced bronchospasm:\u003c\/strong\u003e Take \u003cstrong\u003e2 inhalations 15 to 30 minutes before exercise\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli\u003eAlways shake the inhaler well before use and follow your healthcare provider’s instructions. Avoid exceeding the recommended dosage.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003ePrime the inhaler\u003c\/strong\u003e by spraying 4 test sprays into the air if it hasn’t been used for more than 3 days.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e6. What precautions should you take before using Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eBefore using this medication:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eInform your doctor if you have \u003cstrong\u003eheart disease, high blood pressure, diabetes, seizures, or an overactive thyroid\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli\u003eAvoid using it if you are allergic to Levalbuterol or any of its ingredients.\u003c\/li\u003e\r\n\u003cli\u003eDiscuss its use during \u003cstrong\u003epregnancy or breastfeeding\u003c\/strong\u003e with your doctor.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e7. What are the potential side effects of Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eCommon side effects include:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eNervousness or tremors\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eHeadache\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eDizziness\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eIncreased heart rate (tachycardia)\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eSore throat or cough\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eRare but serious side effects may include:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eChest pain or irregular heartbeat\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eSevere dizziness or fainting\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eParadoxical bronchospasm (worsened breathing)\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eSeek immediate medical attention if any severe reactions occur.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e8. Can Levalbuterol Inhaler be used with other medications?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol may interact with other medications, including:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eBeta-blockers\u003c\/strong\u003e (e.g., propranolol)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDiuretics\u003c\/strong\u003e (may increase the risk of low potassium levels)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eAntidepressants\u003c\/strong\u003e (e.g., monoamine oxidase inhibitors or tricyclics)\u003cbr\u003eAlways inform your doctor about all medications, supplements, or herbal products you are taking.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e9. How should Levalbuterol Inhaler be stored?\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eStore the inhaler at room temperature, \u003cstrong\u003eaway from direct sunlight and heat\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli\u003eDo not puncture or incinerate the canister, even when empty.\u003c\/li\u003e\r\n\u003cli\u003eKeep out of reach of children.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e10. What should you do if you miss a dose or overdose?\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eMissed Dose:\u003c\/strong\u003e Take it as soon as you remember. If it is almost time for your next dose, skip the missed dose—do not double up.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eOverdose:\u003c\/strong\u003e Symptoms of overdose may include chest pain, rapid heart rate, tremors, and feeling nervous. Seek immediate medical help if an overdose occurs.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e11. Is Levalbuterol Inhaler Clinically Approved Pharmaceuticals?\u003c\/strong\u003e\u003cbr\u003eYes, Levalbuterol Inhaler is \u003cstrong\u003eClinically Approved Pharmaceuticals\u003c\/strong\u003e and has been proven to be both safe and effective for its intended uses when taken as directed.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e12. Are there alternatives to Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eYes, alternative medications include \u003cstrong\u003eAlbuterol Inhaler\u003c\/strong\u003e or \u003cstrong\u003eIpratropium\/Albuterol combination therapy\u003c\/strong\u003e, depending on your specific condition and medical history. Consult your doctor to explore alternatives if necessary.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e13. Can Levalbuterol Inhaler be used for long-term control of asthma or COPD?\u003c\/strong\u003e\u003cbr\u003eNo, Levalbuterol is a \u003cstrong\u003erescue inhaler\u003c\/strong\u003e designed for quick relief of acute symptoms. For long-term control, your doctor may prescribe \u003cstrong\u003einhaled corticosteroids\u003c\/strong\u003e or other maintenance medications.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e14. Can you use Levalbuterol Inhaler during pregnancy or breastfeeding?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol is classified as \u003cstrong\u003ePregnancy Category C\u003c\/strong\u003e by the FDA. Its safety during pregnancy and breastfeeding has not been fully established, so it should only be used if clearly needed and prescribed by a healthcare provider.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e15. What should you do if Levalbuterol Inhaler does not relieve symptoms?\u003c\/strong\u003e\u003cbr\u003eIf your symptoms persist or worsen despite using the inhaler, contact your doctor immediately. This could indicate a serious underlying condition or the need to adjust your treatment plan.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003eBy following your doctor’s recommendations and using Levalbuterol Inhaler correctly, you can effectively manage your respiratory symptoms and improve your quality of life.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50mcg\/200mdi","offer_id":51735705813275,"sku":"XOPENEXINHALER50mcg\/200mdi","price":19.99,"currency_code":"USD","in_stock":true}]},{"product_id":"advair-inhaler-1","title":"ADVAIR  Inhaler","description":"\u003ch4\u003eWhat is ADVAIR  Inhaler?\u003c\/h4\u003e\u003cp\u003eADVAIR  Inhaler is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50\/100mcg","offer_id":51735705878811,"sku":"ADVAIR50\/100mcgInhaler","price":58.79,"currency_code":"USD","in_stock":true},{"title":"50\/250mcg","offer_id":51735705911579,"sku":"ADVAIR50\/250mcgInhaler","price":70.55,"currency_code":"USD","in_stock":true},{"title":"50\/500mcg","offer_id":51735705944347,"sku":"ADVAIR50\/500mcgInhaler","price":84.91,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/seretide_water_marked1_1_1.png?v=1770407345"},{"product_id":"advair-rotacaps-250-50mcg","title":"ADVAIR ROTACAPS 250\/50mcg","description":"\u003ch4\u003eWhat is  ADVAIR ROTACAPS 250\/50mcg?\u003c\/h4\u003e\u003cp\u003e ADVAIR ROTACAPS 250\/50mcg is a capsule supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735705977115,"sku":"ADVAIRROTACAPS250\/50mcg","price":16.02,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/seretide_water_marked_2_3.png?v=1770407348"},{"product_id":"advair-rotacaps-500-50mcg","title":"ADVAIR ROTACAPS 500\/50mcg","description":"\u003ch4\u003eWhat is  ADVAIR ROTACAPS 500\/50mcg?\u003c\/h4\u003e\u003cp\u003e ADVAIR ROTACAPS 500\/50mcg is a capsule supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735706009883,"sku":"ADVAIRROTACAPS500\/50mcg","price":18.6,"currency_code":"USD","in_stock":true}]},{"product_id":"levolin-inhaler","title":"Levolin Inhaler","description":"\u003cp\u003e\u003cstrong\u003e1. What is Levalbuterol Inhaler and what is it used for?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol Inhaler is a prescription medication classified as a short-acting beta-agonist (SABA). It is primarily used to treat or prevent bronchospasms in individuals with reversible obstructive airway disease, such as asthma or chronic obstructive pulmonary disease (COPD). It is also used to prevent exercise-induced bronchospasms.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e2. What is the active ingredient in Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eThe active ingredient in this inhaler is \u003cstrong\u003eLevalbuterol Hydrochloride\u003c\/strong\u003e. It works by relaxing the muscles in the airways, improving airflow and making it easier to breathe.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e3. How does Levalbuterol Inhaler work?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol binds to beta-2 adrenergic receptors in the airway smooth muscle. This action triggers the relaxation of the muscles, reducing airway constriction, and alleviating symptoms like wheezing, shortness of breath, and chest tightness.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e4. Who can use Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol Inhaler is approved for use in both adults and children aged \u003cstrong\u003e4 years and older\u003c\/strong\u003e. However, its use should be guided by a healthcare provider, especially in children or patients with pre-existing medical conditions.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e5. How should Levalbuterol Inhaler be used?\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eFor bronchospasm treatment:\u003c\/strong\u003e Take \u003cstrong\u003e2 inhalations every 4 to 6 hours\u003c\/strong\u003e, as needed.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eFor exercise-induced bronchospasm:\u003c\/strong\u003e Take \u003cstrong\u003e2 inhalations 15 to 30 minutes before exercise\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli\u003eAlways shake the inhaler well before use and follow your healthcare provider’s instructions. Avoid exceeding the recommended dosage.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003ePrime the inhaler\u003c\/strong\u003e by spraying 4 test sprays into the air if it hasn’t been used for more than 3 days.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e6. What precautions should you take before using Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eBefore using this medication:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eInform your doctor if you have \u003cstrong\u003eheart disease, high blood pressure, diabetes, seizures, or an overactive thyroid\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli\u003eAvoid using it if you are allergic to Levalbuterol or any of its ingredients.\u003c\/li\u003e\r\n\u003cli\u003eDiscuss its use during \u003cstrong\u003epregnancy or breastfeeding\u003c\/strong\u003e with your doctor.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e7. What are the potential side effects of Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eCommon side effects include:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eNervousness or tremors\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eHeadache\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eDizziness\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eIncreased heart rate (tachycardia)\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eSore throat or cough\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eRare but serious side effects may include:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eChest pain or irregular heartbeat\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eSevere dizziness or fainting\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eParadoxical bronchospasm (worsened breathing)\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eSeek immediate medical attention if any severe reactions occur.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e8. Can Levalbuterol Inhaler be used with other medications?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol may interact with other medications, including:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eBeta-blockers\u003c\/strong\u003e (e.g., propranolol)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDiuretics\u003c\/strong\u003e (may increase the risk of low potassium levels)\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eAntidepressants\u003c\/strong\u003e (e.g., monoamine oxidase inhibitors or tricyclics)\u003cbr\u003eAlways inform your doctor about all medications, supplements, or herbal products you are taking.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e9. How should Levalbuterol Inhaler be stored?\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eStore the inhaler at room temperature, \u003cstrong\u003eaway from direct sunlight and heat\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli\u003eDo not puncture or incinerate the canister, even when empty.\u003c\/li\u003e\r\n\u003cli\u003eKeep out of reach of children.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e10. What should you do if you miss a dose or overdose?\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eMissed Dose:\u003c\/strong\u003e Take it as soon as you remember. If it is almost time for your next dose, skip the missed dose—do not double up.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eOverdose:\u003c\/strong\u003e Symptoms of overdose may include chest pain, rapid heart rate, tremors, and feeling nervous. Seek immediate medical help if an overdose occurs.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e11. Is Levalbuterol Inhaler Clinically Approved Pharmaceuticals?\u003c\/strong\u003e\u003cbr\u003eYes, Levalbuterol Inhaler is \u003cstrong\u003eClinically Approved Pharmaceuticals\u003c\/strong\u003e and has been proven to be both safe and effective for its intended uses when taken as directed.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e12. Are there alternatives to Levalbuterol Inhaler?\u003c\/strong\u003e\u003cbr\u003eYes, alternative medications include \u003cstrong\u003eAlbuterol Inhaler\u003c\/strong\u003e or \u003cstrong\u003eIpratropium\/Albuterol combination therapy\u003c\/strong\u003e, depending on your specific condition and medical history. Consult your doctor to explore alternatives if necessary.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e13. Can Levalbuterol Inhaler be used for long-term control of asthma or COPD?\u003c\/strong\u003e\u003cbr\u003eNo, Levalbuterol is a \u003cstrong\u003erescue inhaler\u003c\/strong\u003e designed for quick relief of acute symptoms. For long-term control, your doctor may prescribe \u003cstrong\u003einhaled corticosteroids\u003c\/strong\u003e or other maintenance medications.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e14. Can you use Levalbuterol Inhaler during pregnancy or breastfeeding?\u003c\/strong\u003e\u003cbr\u003eLevalbuterol is classified as \u003cstrong\u003ePregnancy Category C\u003c\/strong\u003e by the FDA. Its safety during pregnancy and breastfeeding has not been fully established, so it should only be used if clearly needed and prescribed by a healthcare provider.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003e\u003cstrong\u003e15. What should you do if Levalbuterol Inhaler does not relieve symptoms?\u003c\/strong\u003e\u003cbr\u003eIf your symptoms persist or worsen despite using the inhaler, contact your doctor immediately. This could indicate a serious underlying condition or the need to adjust your treatment plan.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003cp\u003eBy following your doctor’s recommendations and using Levalbuterol Inhaler correctly, you can effectively manage your respiratory symptoms and improve your quality of life.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50mcg\/200mdi","offer_id":51735706042651,"sku":"Levolin Inhaler-50mcg\/200mdi","price":17.46,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_24.png?v=1770407352"},{"product_id":"seretra","title":"Seretra","description":"\u003ch3 data-start=\"299\" data-end=\"325\"\u003eWhat is Seratrodast?\u003c\/h3\u003e\r\n\u003cp data-start=\"326\" data-end=\"679\"\u003e\u003cstrong data-start=\"326\" data-end=\"341\"\u003eSeratrodast\u003c\/strong\u003e is a selective thromboxane A₂ receptor antagonist used primarily for the management of allergic conditions, including bronchial asthma and allergic rhinitis. It works by blocking the effects of thromboxane A₂—a potent mediator of bronchoconstriction and inflammation—thereby helping to reduce airway narrowing and inflammatory responses.\u003c\/p\u003e\r\n\u003cp data-start=\"681\" data-end=\"776\"\u003e\u003cem data-start=\"681\" data-end=\"776\"\u003eReference: U.S. Food and Drug Administration (FDA); WHO; PubMed (e.g., Ishiguro et al., 2000)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"778\" data-end=\"781\"\u003e\r\n\u003ch3 data-start=\"783\" data-end=\"838\"\u003eWhat are the other popular names for Seratrodast?\u003c\/h3\u003e\r\n\u003cp data-start=\"839\" data-end=\"1104\"\u003eSeratrodast is known by its generic name “seratrodast” and is marketed under various brand names depending on the region. In some markets, it may be available under brand names such as \u003cstrong data-start=\"1024\" data-end=\"1035\"\u003eSeratol\u003c\/strong\u003e or \u003cstrong data-start=\"1039\" data-end=\"1051\"\u003eSeratast\u003c\/strong\u003e, though naming conventions can vary internationally.\u003c\/p\u003e\r\n\u003cp data-start=\"1106\" data-end=\"1145\"\u003e\u003cem data-start=\"1106\" data-end=\"1145\"\u003eReference: U.S. FDA; MedlinePlus; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1147\" data-end=\"1150\"\u003e\r\n\u003ch3 data-start=\"1152\" data-end=\"1205\"\u003eWhat is the drug classification of Seratrodast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1206\" data-end=\"1464\"\u003eSeratrodast is classified as an \u003cstrong data-start=\"1238\" data-end=\"1260\"\u003eantiallergic agent\u003c\/strong\u003e and, more specifically, as a \u003cstrong data-start=\"1290\" data-end=\"1338\"\u003eselective thromboxane A₂ receptor antagonist\u003c\/strong\u003e. It belongs to a group of medications used to manage allergic inflammation and bronchoconstriction in respiratory conditions.\u003c\/p\u003e\r\n\u003cp data-start=\"1466\" data-end=\"1552\"\u003e\u003cem data-start=\"1466\" data-end=\"1552\"\u003eReference: U.S. FDA; World Health Organization (WHO) guidelines on allergic diseases\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1554\" data-end=\"1557\"\u003e\r\n\u003ch3 data-start=\"1559\" data-end=\"1607\"\u003eWhat is the mode of action of Seratrodast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1608\" data-end=\"1954\"\u003eSeratrodast works by selectively blocking thromboxane A₂ (TXA₂) receptors on airway smooth muscle and inflammatory cells. By inhibiting the action of TXA₂, it reduces bronchoconstriction and limits the release of inflammatory mediators. This action helps improve airflow and reduces symptoms associated with allergic asthma and allergic rhinitis.\u003c\/p\u003e\r\n\u003cp data-start=\"1956\" data-end=\"2066\"\u003e\u003cem data-start=\"1956\" data-end=\"2066\"\u003eReference: PubMed – Studies on thromboxane receptor antagonists in asthma (e.g., Ishiguro et al., 2000); WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2068\" data-end=\"2071\"\u003e\r\n\u003ch3 data-start=\"2073\" data-end=\"2120\"\u003eWhat are the primary uses of Seratrodast?\u003c\/h3\u003e\r\n\u003cp data-start=\"2121\" data-end=\"2172\"\u003eSeratrodast is used primarily in the management of:\u003c\/p\u003e\r\n\u003cul data-start=\"2173\" data-end=\"2408\"\u003e\r\n\u003cli data-start=\"2173\" data-end=\"2246\"\u003e\n\u003cstrong data-start=\"2175\" data-end=\"2205\"\u003eAllergic Bronchial Asthma:\u003c\/strong\u003e To reduce bronchospasm and inflammation.\u003c\/li\u003e\r\n\u003cli data-start=\"2247\" data-end=\"2321\"\u003e\n\u003cstrong data-start=\"2249\" data-end=\"2271\"\u003eAllergic Rhinitis:\u003c\/strong\u003e To alleviate nasal symptoms related to allergies.\u003c\/li\u003e\r\n\u003cli data-start=\"2322\" data-end=\"2408\"\u003e\n\u003cstrong data-start=\"2324\" data-end=\"2354\"\u003eOther Allergic Conditions:\u003c\/strong\u003e Where thromboxane-mediated inflammation plays a role.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2410\" data-end=\"2456\"\u003e\u003cem data-start=\"2410\" data-end=\"2456\"\u003eReference: U.S. FDA; WHO; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2458\" data-end=\"2461\"\u003e\r\n\u003ch3 data-start=\"2463\" data-end=\"2535\"\u003eWhat is the recommended dosage and administration for Seratrodast?\u003c\/h3\u003e\r\n\u003cul data-start=\"2536\" data-end=\"2877\"\u003e\r\n\u003cli data-start=\"2536\" data-end=\"2638\"\u003e\n\u003cstrong data-start=\"2538\" data-end=\"2549\"\u003eDosage:\u003c\/strong\u003e In adults, the typical dosage is \u003cstrong data-start=\"2583\" data-end=\"2601\"\u003e100 mg per day\u003c\/strong\u003e, often given as 50 mg twice daily.\u003c\/li\u003e\r\n\u003cli data-start=\"2639\" data-end=\"2877\"\u003e\n\u003cstrong data-start=\"2641\" data-end=\"2660\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2665\" data-end=\"2877\"\u003e\r\n\u003cli data-start=\"2665\" data-end=\"2721\"\u003eSeratrodast tablets should be taken orally with water.\u003c\/li\u003e\r\n\u003cli data-start=\"2724\" data-end=\"2793\"\u003eIt is best taken with food to minimize gastrointestinal discomfort.\u003c\/li\u003e\r\n\u003cli data-start=\"2796\" data-end=\"2877\"\u003eDosage adjustments may be required based on clinical response and tolerability.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2879\" data-end=\"2956\"\u003e\u003cem data-start=\"2879\" data-end=\"2956\"\u003eReference: PubMed (e.g., clinical study by Ishiguro et al., 2000); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2958\" data-end=\"2961\"\u003e\r\n\u003ch3 data-start=\"2963\" data-end=\"3027\"\u003eWhat prescribing information is important for Seratrodast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3028\" data-end=\"3599\"\u003e\r\n\u003cli data-start=\"3028\" data-end=\"3224\"\u003e\n\u003cstrong data-start=\"3030\" data-end=\"3046\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3051\" data-end=\"3224\"\u003e\r\n\u003cli data-start=\"3051\" data-end=\"3224\"\u003eIndicated for the treatment of allergic bronchial asthma and allergic rhinitis, particularly in patients who do not achieve adequate symptom control with standard therapy.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3225\" data-end=\"3417\"\u003e\n\u003cstrong data-start=\"3227\" data-end=\"3249\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3254\" data-end=\"3417\"\u003e\r\n\u003cli data-start=\"3254\" data-end=\"3352\"\u003eContraindicated in patients with known hypersensitivity to seratrodast or any of its components.\u003c\/li\u003e\r\n\u003cli data-start=\"3355\" data-end=\"3417\"\u003eUse with caution in patients with severe hepatic impairment.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3418\" data-end=\"3599\"\u003e\n\u003cstrong data-start=\"3420\" data-end=\"3435\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3440\" data-end=\"3599\"\u003e\r\n\u003cli data-start=\"3440\" data-end=\"3545\"\u003eLiver function tests should be monitored periodically in patients with pre-existing hepatic conditions.\u003c\/li\u003e\r\n\u003cli data-start=\"3548\" data-end=\"3599\"\u003eSymptom improvement should be assessed regularly.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3601\" data-end=\"3647\"\u003e\u003cem data-start=\"3601\" data-end=\"3647\"\u003eReference: U.S. FDA; WHO; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3649\" data-end=\"3652\"\u003e\r\n\u003ch3 data-start=\"3654\" data-end=\"3754\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Seratrodast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3755\" data-end=\"4457\"\u003e\r\n\u003cli data-start=\"3755\" data-end=\"3878\"\u003e\n\u003cstrong data-start=\"3757\" data-end=\"3781\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3786\" data-end=\"3878\"\u003e\r\n\u003cli data-start=\"3786\" data-end=\"3878\"\u003eHeadache, gastrointestinal discomfort (nausea, dyspepsia), and mild skin reactions (rash).\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3879\" data-end=\"4008\"\u003e\n\u003cstrong data-start=\"3881\" data-end=\"3913\"\u003eSerious Side Effects (Rare):\u003c\/strong\u003e\r\n\u003cul data-start=\"3918\" data-end=\"4008\"\u003e\r\n\u003cli data-start=\"3918\" data-end=\"3955\"\u003eDizziness or hypotension may occur.\u003c\/li\u003e\r\n\u003cli data-start=\"3958\" data-end=\"4008\"\u003eIn rare cases, allergic reactions can be severe.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4009\" data-end=\"4457\"\u003e\n\u003cstrong data-start=\"4011\" data-end=\"4035\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4040\" data-end=\"4457\"\u003e\r\n\u003cli data-start=\"4040\" data-end=\"4120\"\u003e\n\u003cstrong data-start=\"4042\" data-end=\"4062\"\u003eHepatic Caution:\u003c\/strong\u003e Monitor liver enzymes in patients with liver dysfunction.\u003c\/li\u003e\r\n\u003cli data-start=\"4123\" data-end=\"4298\"\u003e\n\u003cstrong data-start=\"4125\" data-end=\"4153\"\u003ePregnancy and Lactation:\u003c\/strong\u003e Limited data exist; use only if the potential benefit justifies the risk. Effective contraception is advised in women of childbearing potential.\u003c\/li\u003e\r\n\u003cli data-start=\"4301\" data-end=\"4457\"\u003e\n\u003cstrong data-start=\"4303\" data-end=\"4325\"\u003eDrug Interactions:\u003c\/strong\u003e Caution is warranted when seratrodast is used concurrently with other agents that may affect its metabolism (e.g., CYP inhibitors).\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4459\" data-end=\"4493\"\u003e\u003cem data-start=\"4459\" data-end=\"4493\"\u003eReference: U.S. FDA; PubMed; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4495\" data-end=\"4498\"\u003e\r\n\u003ch3 data-start=\"4500\" data-end=\"4567\"\u003eWhat drug interactions should be considered with Seratrodast?\u003c\/h3\u003e\r\n\u003cul data-start=\"4568\" data-end=\"5040\"\u003e\r\n\u003cli data-start=\"4568\" data-end=\"4750\"\u003e\n\u003cstrong data-start=\"4570\" data-end=\"4596\"\u003eCYP Enzyme Modulators:\u003c\/strong\u003e\r\n\u003cul data-start=\"4601\" data-end=\"4750\"\u003e\r\n\u003cli data-start=\"4601\" data-end=\"4750\"\u003eConcomitant use with drugs that inhibit CYP450 enzymes (e.g., certain antifungals or macrolide antibiotics) may increase seratrodast plasma levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4751\" data-end=\"4916\"\u003e\n\u003cstrong data-start=\"4753\" data-end=\"4789\"\u003eOther Anti-Allergic Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"4794\" data-end=\"4916\"\u003e\r\n\u003cli data-start=\"4794\" data-end=\"4916\"\u003eConcurrent use with other antiallergic or anti-inflammatory agents may require dose adjustments or increased monitoring.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4917\" data-end=\"5040\"\u003e\n\u003cstrong data-start=\"4919\" data-end=\"4941\"\u003eHepatotoxic Drugs:\u003c\/strong\u003e\r\n\u003cul data-start=\"4946\" data-end=\"5040\"\u003e\r\n\u003cli data-start=\"4946\" data-end=\"5040\"\u003eUse with other medications known to impact liver function should be approached with caution.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5042\" data-end=\"5104\"\u003e\u003cem data-start=\"5042\" data-end=\"5104\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5106\" data-end=\"5109\"\u003e\r\n\u003ch3 data-start=\"5111\" data-end=\"5206\"\u003eWhere can I find additional clinical evidence and detailed information about Seratrodast?\u003c\/h3\u003e\r\n\u003cp data-start=\"5207\" data-end=\"5291\"\u003eFor further details on clinical studies, dosing guidelines, and safety monitoring:\u003c\/p\u003e\r\n\u003cul data-start=\"5292\" data-end=\"5653\"\u003e\r\n\u003cli data-start=\"5292\" data-end=\"5380\"\u003e\n\u003cstrong data-start=\"5294\" data-end=\"5346\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"5347\" data-end=\"5378\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"5381\" data-end=\"5439\"\u003e\n\u003cstrong data-start=\"5383\" data-end=\"5406\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for seratrodast studies\u003c\/li\u003e\r\n\u003cli data-start=\"5440\" data-end=\"5558\"\u003e\n\u003cstrong data-start=\"5442\" data-end=\"5453\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on seratrodast’s efficacy and safety (e.g., Ishiguro et al., 2000)\u003c\/li\u003e\r\n\u003cli data-start=\"5559\" data-end=\"5653\"\u003e\n\u003cstrong data-start=\"5561\" data-end=\"5597\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e Guidelines on allergic diseases and treatment protocols\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5655\" data-end=\"5689\"\u003e\u003cem data-start=\"5655\" data-end=\"5689\"\u003eReference: U.S. FDA; PubMed; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5691\" data-end=\"5694\"\u003e\r\n\u003ch3 data-start=\"5696\" data-end=\"5716\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"5717\" data-end=\"6376\"\u003e\u003cstrong data-start=\"5717\" data-end=\"5732\"\u003eSeratrodast\u003c\/strong\u003e is a valuable selective thromboxane A₂ receptor antagonist used to manage allergic bronchial asthma and allergic rhinitis by reducing bronchoconstriction and inflammation. Its ability to improve airflow and alleviate allergic symptoms makes it a beneficial addition to treatment regimens for patients inadequately controlled by conventional therapies. However, due to potential hepatic concerns and drug interactions, careful patient selection, dosing, and monitoring are essential. Always consult with your healthcare provider to determine if seratrodast is appropriate for your condition and to tailor the treatment to your individual needs.\u003c\/p\u003e\r\n\u003cp data-start=\"6378\" data-end=\"6602\"\u003e\u003cem data-start=\"6378\" data-end=\"6602\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"80mg","offer_id":51735706075419,"sku":"Seretra-80mg","price":38.88,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_68.png?v=1770407355"},{"product_id":"norphyl-injection-25mg-ml-10ml-amp","title":"NORPHYL INJECTION 25mg\/ml (10ml amp)","description":"\n\u003cdiv class=\"product-description\"\u003e\n    \u003ch2\u003eOverview\u003c\/h2\u003e\n    \u003cp\u003eNORPHYL INJECTION 25mg\/ml is a sterile solution containing Aminophylline, a bronchodilator used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It helps to relax the muscles around the airways, making it easier to breathe.\u003c\/p\u003e\n\n    \u003ch2\u003eBenefits\u003c\/h2\u003e\n    \u003cul\u003e\n        \u003cli\u003eRelieves symptoms of asthma and COPD.\u003c\/li\u003e\n        \u003cli\u003eImproves airflow to the lungs.\u003c\/li\u003e\n        \u003cli\u003eReduces the frequency and severity of asthma attacks.\u003c\/li\u003e\n        \u003cli\u003eAvailable in an easy-to-administer injection form.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003ch2\u003eDosage\u003c\/h2\u003e\n    \u003cp\u003eThe dosage of NORPHYL INJECTION should be determined by a healthcare professional based on the patient's condition and response to treatment. It is typically administered via intramuscular or intravenous injection.\u003c\/p\u003e\n\n    \u003ch2\u003eSide Effects\u003c\/h2\u003e\n    \u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n    \u003cul\u003e\n        \u003cli\u003eNausea or vomiting\u003c\/li\u003e\n        \u003cli\u003eHeadache\u003c\/li\u003e\n        \u003cli\u003eIncreased heart rate\u003c\/li\u003e\n        \u003cli\u003eInsomnia\u003c\/li\u003e\n        \u003cli\u003eRestlessness\u003c\/li\u003e\n    \u003c\/ul\u003e\n    \u003cp\u003eIf you experience severe side effects or allergic reactions, seek medical attention immediately.\u003c\/p\u003e\n\n    \u003ch2\u003eFAQs\u003c\/h2\u003e\n    \u003ch3\u003eWhat is Aminophylline?\u003c\/h3\u003e\n    \u003cp\u003eAminophylline is a medication that relaxes the muscles of the airways and is used to treat breathing problems.\u003c\/p\u003e\n\n    \u003ch3\u003eHow is NORPHYL INJECTION administered?\u003c\/h3\u003e\n    \u003cp\u003eNORPHYL INJECTION is administered by a healthcare professional through an injection into the muscle or vein.\u003c\/p\u003e\n\n    \u003ch3\u003eCan I use NORPHYL INJECTION if I am pregnant?\u003c\/h3\u003e\n    \u003cp\u003eConsult your healthcare provider before using NORPHYL INJECTION if you are pregnant or planning to become pregnant.\u003c\/p\u003e\n\n    \u003ch3\u003eWhat should I do if I miss a dose?\u003c\/h3\u003e\n    \u003cp\u003eIf you miss a dose, contact your healthcare provider for instructions. Do not double the dose to catch up.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735706140955,"sku":"config_Aminophylline_25mg\/m2856","price":27.4,"currency_code":"USD","in_stock":true}]},{"product_id":"advair-25-125mcg-inhaler","title":"ADVAIR 25\/125mcg Inhaler","description":"\n\u003ch4\u003eADVAIR 25\/125mcg Inhaler (Salmeterol\/Fluticasone Propionate)\u003c\/h4\u003e\n\u003cp\u003eADVAIR is a prescription medication that combines two active ingredients: Salmeterol and Fluticasone Propionate. This inhaler is primarily used for the management of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways and reducing inflammation, making it easier to breathe.\u003c\/p\u003e\n\n\u003ch4\u003eHow It Works\u003c\/h4\u003e\n\u003cp\u003eSalmeterol is a long-acting beta-agonist (LABA) that helps to open the airways, while Fluticasone Propionate is a corticosteroid that reduces inflammation in the lungs. Together, they provide effective relief from symptoms such as wheezing, shortness of breath, and chest tightness.\u003c\/p\u003e\n\n\u003ch4\u003eAdministration\u003c\/h4\u003e\n\u003cp\u003eADVAIR is administered via an inhaler. It is important to follow your healthcare provider's instructions regarding dosage and usage. Typically, the inhaler is used twice daily, with doses taken approximately 12 hours apart.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of ADVAIR may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eHeadache\u003c\/li\u003e\n    \u003cli\u003eThroat irritation\u003c\/li\u003e\n    \u003cli\u003eCough\u003c\/li\u003e\n    \u003cli\u003eIncreased heart rate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore using ADVAIR, inform your doctor about any medical conditions or allergies you may have, as well as any other medications you are currently taking. This medication is not suitable for individuals who have certain heart conditions or asthma that is well-controlled with other treatments.\u003c\/p\u003e\n\n\u003ch4\u003eConsultation\u003c\/h4\u003e\n\u003cp\u003eAlways consult with your healthcare provider for personalized advice and to ensure that ADVAIR is the right option for your asthma or COPD management. Regular follow-ups are essential to monitor your condition and adjust treatment as needed.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore ADVAIR inhalers at room temperature, away from moisture and heat. Keep out of reach of children.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735706173723,"sku":"config_Salmeterol\/Fluticasone_Propionate_25\/125mcg51","price":104.1,"currency_code":"USD","in_stock":true}]},{"product_id":"advair-25-250mcg-inhaler","title":"ADVAIR 25\/250mcg Inhaler","description":"\n\u003ch4\u003eADVAIR 25\/250mcg Inhaler (Salmeterol\/Fluticasone Propionate)\u003c\/h4\u003e\n\u003cp\u003eADVAIR is a prescription medication that combines two active ingredients: Salmeterol, a long-acting beta-agonist (LABA), and Fluticasone Propionate, a corticosteroid. This combination works to control asthma and chronic obstructive pulmonary disease (COPD) symptoms by reducing inflammation and opening the airways.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eADVAIR is indicated for the treatment of asthma and COPD in patients who require a combination of both a long-acting bronchodilator and an inhaled corticosteroid. It is intended for use in patients aged 4 years and older.\u003c\/p\u003e\n\n\u003ch4\u003eHow to Use\u003c\/h4\u003e\n\u003cp\u003eTo use the ADVAIR inhaler, follow these steps:\u003c\/p\u003e\n\u003col\u003e\n    \u003cli\u003eShake the inhaler well before each use.\u003c\/li\u003e\n    \u003cli\u003eRemove the cap from the mouthpiece.\u003c\/li\u003e\n    \u003cli\u003eExhale fully before placing the mouthpiece in your mouth.\u003c\/li\u003e\n    \u003cli\u003ePress down on the inhaler to release the medication while inhaling deeply and slowly.\u003c\/li\u003e\n    \u003cli\u003eHold your breath for 10 seconds to allow the medication to settle in your lungs.\u003c\/li\u003e\n    \u003cli\u003eRepeat if prescribed, and replace the cap after use.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch4\u003eDosage\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of ADVAIR varies based on the patient's condition and response to treatment. It is important to follow your healthcare provider's instructions regarding dosing.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eHeadache\u003c\/li\u003e\n    \u003cli\u003eThroat irritation\u003c\/li\u003e\n    \u003cli\u003eMuscle pain\u003c\/li\u003e\n    \u003cli\u003eIncreased heart rate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you experience severe side effects such as difficulty breathing, swelling of the face or throat, or rapid heartbeat, seek medical attention immediately.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore using ADVAIR, inform your healthcare provider about any existing medical conditions, especially heart problems, high blood pressure, diabetes, or a history of seizures. This medication should not be used for the treatment of acute asthma attacks.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore the inhaler at room temperature, away from moisture and heat. Do not puncture or burn the inhaler, even if it appears empty.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eADVAIR 25\/250mcg Inhaler is an effective treatment option for managing asthma and COPD symptoms. Always consult your healthcare provider for personalized medical advice and to ensure safe use of this medication.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735706239259,"sku":"config_Salmeterol\/Fluticasone_Propionate_25\/250mcg54","price":104.02,"currency_code":"USD","in_stock":true}]},{"product_id":"trelegy-ellipta-powder-for-inhalation","title":"Trelegy Ellipta Powder for inhalation","description":"\u003ch3\u003e\u003cspan style=\"font-size: 16px;\"\u003eDrug Description for Trelegy Ellipta\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eProduct Name:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eTrelegy Ellipta\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eDrug Class and Categories:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eDrug Class:\u003c\/strong\u003e Respiratory Agents, Combination\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eCategories:\u003c\/strong\u003e Long-Acting Beta2-Agonists (LABA), Inhaled Corticosteroids (ICS), Long-Acting Muscarinic Antagonists (LAMA)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eActive Ingredient:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eFluticasone Furoate (Inhaled Corticosteroid)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eUmeclidinium (Long-Acting Muscarinic Antagonist)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eVilanterol (Long-Acting Beta2-Agonist)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eOther Names:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eTrelegy\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eMode of Action:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eTrelegy Ellipta combines three medications in one inhaler to provide comprehensive management of chronic obstructive pulmonary disease (COPD) and asthma. Fluticasone furoate reduces inflammation in the lungs, umeclidinium relaxes airway muscles to open airways, and vilanterol relaxes bronchial muscles to ease breathing. Together, they improve lung function and reduce COPD exacerbations.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eHow to Use:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eUse Trelegy Ellipta exactly as prescribed by your healthcare provider.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eInhale once daily at the same time each day.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eFollow the instructions for using the Ellipta inhaler properly to ensure you receive the correct dose.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eRecommended Dosage:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eAdults with COPD or Asthma:\u003c\/strong\u003e One inhalation once daily, preferably at the same time each day.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eDirections:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eOpen the cover of the inhaler and slide down the mouthpiece cover until you hear a click.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eExhale fully before placing the mouthpiece in your mouth.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eInhale the medication deeply and hold your breath for about 10 seconds.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eExhale slowly and close the mouthpiece cover until it clicks into place.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eCautions:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eDo not use Trelegy Ellipta to treat acute bronchospasm or asthma attacks.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eInform your healthcare provider of any allergies, especially to fluticasone, umeclidinium, or vilanterol.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eLong-term use may increase the risk of pneumonia in patients with COPD.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eRegular monitoring of lung function is recommended.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eGuidelines:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eRinse your mouth with water without swallowing after using the inhaler to reduce the risk of oral thrush.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eStore Trelegy Ellipta at room temperature, away from moisture and heat.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eKeep the inhaler out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eDiscard the inhaler 6 weeks after opening or when the dose counter reads \"0,\" whichever comes first.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eFrequently Asked Questions (FAQs):\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: What should I do if I miss a dose of Trelegy Ellipta?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e A: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for a missed dose.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Can Trelegy Ellipta be used to treat asthma?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Yes, Trelegy Ellipta is approved for the treatment of asthma in adults who require a combination of an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta2-agonist.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: What are the common side effects of Trelegy Ellipta?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Common side effects include upper respiratory tract infections, headache, back pain, and oral thrush. Contact your healthcare provider if these effects persist or worsen.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Can I use Trelegy Ellipta with other medications?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Some medications can interact with Trelegy Ellipta. Inform your healthcare provider about all the medications and supplements you are taking.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Is Trelegy Ellipta safe during pregnancy?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: The safety of Trelegy Ellipta during pregnancy is not well established. If you are pregnant or planning to become pregnant, consult your healthcare provider to weigh the potential benefits and risks.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: How should I store Trelegy Ellipta?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Store at room temperature, away from moisture and heat. Keep the inhaler in its sealed tray until ready for use.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: How long does it take for Trelegy Ellipta to start working?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Some patients may experience an improvement in breathing within 24 hours, but it may take several days to experience the full benefits of the medication.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Can I use Trelegy Ellipta for an asthma attack?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: No, Trelegy Ellipta is not intended for the relief of acute bronchospasm or asthma attacks. Use a rescue inhaler for sudden breathing problems.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: How often should I use Trelegy Ellipta?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Use Trelegy Ellipta once daily, at the same time each day. Do not use it more than once every 24 hours.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: What if I experience severe side effects while using Trelegy Ellipta?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e A: Seek immediate medical attention if you experience symptoms such as severe allergic reactions, difficulty breathing, or severe chest pain.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eBy following these guidelines and using Trelegy Ellipta as prescribed, you can effectively manage COPD or asthma and maintain your respiratory health. Always consult your healthcare provider for personalized advice and information.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch3 data-start=\"275\" data-end=\"305\"\u003eWhat is Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"306\" data-end=\"526\"\u003e\u003cstrong data-start=\"306\" data-end=\"325\"\u003eTrelegy Ellipta\u003c\/strong\u003e is a once‑daily, triple‑therapy inhaler approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and, in some regions, for asthma. It combines three active ingredients:\u003c\/p\u003e\r\n\u003cul data-start=\"527\" data-end=\"855\"\u003e\r\n\u003cli data-start=\"527\" data-end=\"621\"\u003e\n\u003cstrong data-start=\"529\" data-end=\"553\"\u003eFluticasone Furoate:\u003c\/strong\u003e An inhaled corticosteroid (ICS) that reduces airway inflammation.\u003c\/li\u003e\r\n\u003cli data-start=\"622\" data-end=\"754\"\u003e\n\u003cstrong data-start=\"624\" data-end=\"641\"\u003eUmeclidinium:\u003c\/strong\u003e A long‑acting muscarinic antagonist (LAMA) that relaxes airway smooth muscle by blocking muscarinic receptors.\u003c\/li\u003e\r\n\u003cli data-start=\"755\" data-end=\"855\"\u003e\n\u003cstrong data-start=\"757\" data-end=\"772\"\u003eVilanterol:\u003c\/strong\u003e A long‑acting beta‑agonist (LABA) that induces bronchodilation to improve airflow.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"857\" data-end=\"973\"\u003e\u003cem data-start=\"857\" data-end=\"973\"\u003eReference: U.S. Food and Drug Administration (FDA) prescribing information; ClinicalTrials.gov (e.g., NCT02222720)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"975\" data-end=\"978\"\u003e\r\n\u003ch3 data-start=\"980\" data-end=\"1039\"\u003eWhat are the other popular names for Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1040\" data-end=\"1278\"\u003eTrelegy Ellipta is primarily known by its brand name \u003cstrong data-start=\"1093\" data-end=\"1112\"\u003eTrelegy Ellipta\u003c\/strong\u003e. It is sometimes referred to simply as \u003cstrong data-start=\"1152\" data-end=\"1163\"\u003eTrelegy\u003c\/strong\u003e in clinical and patient communications. Its individual components are widely recognized under their generic names.\u003c\/p\u003e\r\n\u003cp data-start=\"1280\" data-end=\"1357\"\u003e\u003cem data-start=\"1280\" data-end=\"1357\"\u003eReference: U.S. FDA; National Institutes of Health (NIH) clinical resources\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1359\" data-end=\"1362\"\u003e\r\n\u003ch3 data-start=\"1364\" data-end=\"1421\"\u003eWhat is the drug classification of Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1422\" data-end=\"1695\"\u003eTrelegy Ellipta is classified as a \u003cstrong data-start=\"1457\" data-end=\"1491\"\u003ecombination inhaled medication\u003c\/strong\u003e for respiratory diseases. It falls under the therapeutic category of \u003cstrong data-start=\"1561\" data-end=\"1588\"\u003etriple therapy for COPD\u003c\/strong\u003e, combining an inhaled corticosteroid, a long‑acting muscarinic antagonist, and a long‑acting beta‑agonist.\u003c\/p\u003e\r\n\u003cp data-start=\"1697\" data-end=\"1757\"\u003e\u003cem data-start=\"1697\" data-end=\"1757\"\u003eReference: American Thoracic Society (ATS) guidelines; FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1759\" data-end=\"1762\"\u003e\r\n\u003ch3 data-start=\"1764\" data-end=\"1816\"\u003eWhat is the mode of action of Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1817\" data-end=\"1900\"\u003eTrelegy Ellipta works via a synergistic mechanism involving its three components:\u003c\/p\u003e\r\n\u003cul data-start=\"1901\" data-end=\"2378\"\u003e\r\n\u003cli data-start=\"1901\" data-end=\"1996\"\u003e\n\u003cstrong data-start=\"1903\" data-end=\"1933\"\u003eFluticasone Furoate (ICS):\u003c\/strong\u003e Reduces airway inflammation and helps prevent exacerbations.\u003c\/li\u003e\r\n\u003cli data-start=\"1997\" data-end=\"2136\"\u003e\n\u003cstrong data-start=\"1999\" data-end=\"2023\"\u003eUmeclidinium (LAMA):\u003c\/strong\u003e Blocks muscarinic receptors, leading to relaxation of airway smooth muscles and decreased bronchoconstriction.\u003c\/li\u003e\r\n\u003cli data-start=\"2137\" data-end=\"2378\"\u003e\n\u003cstrong data-start=\"2139\" data-end=\"2161\"\u003eVilanterol (LABA):\u003c\/strong\u003e Stimulates beta2‑adrenergic receptors, promoting bronchodilation and improved airflow.\u003cbr data-start=\"2248\" data-end=\"2251\"\u003eTogether, these actions enhance lung function, reduce symptoms, and lower the frequency of exacerbations in patients with COPD.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2380\" data-end=\"2461\"\u003e\u003cem data-start=\"2380\" data-end=\"2461\"\u003eReference: New England Journal of Medicine (NEJM); U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2463\" data-end=\"2466\"\u003e\r\n\u003ch3 data-start=\"2468\" data-end=\"2502\"\u003eHow is Trelegy Ellipta used?\u003c\/h3\u003e\r\n\u003cp data-start=\"2503\" data-end=\"2868\"\u003eTrelegy Ellipta is indicated for the long‑term maintenance treatment of patients with COPD to reduce the risk of moderate to severe exacerbations and improve lung function. In some regions, it is also approved for asthma maintenance in patients who require both an ICS and long‑acting bronchodilator therapy. It is not intended for the relief of acute bronchospasm.\u003c\/p\u003e\r\n\u003cp data-start=\"2870\" data-end=\"2935\"\u003e\u003cem data-start=\"2870\" data-end=\"2935\"\u003eReference: U.S. FDA; American Thoracic Society (ATS) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2937\" data-end=\"2940\"\u003e\r\n\u003ch3 data-start=\"2942\" data-end=\"3018\"\u003eWhat is the recommended dosage and administration for Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"3019\" data-end=\"3470\"\u003e\r\n\u003cli data-start=\"3019\" data-end=\"3300\"\u003e\n\u003cstrong data-start=\"3021\" data-end=\"3032\"\u003eDosage:\u003c\/strong\u003e The standard regimen is \u003cstrong data-start=\"3057\" data-end=\"3086\"\u003eone inhalation once daily\u003c\/strong\u003e. The inhaler delivers a fixed dose of the three active ingredients (approximately 100 mcg fluticasone furoate, 62.5 mcg umeclidinium, and 25 mcg vilanterol), although exact dosing may vary by regional approvals.\u003c\/li\u003e\r\n\u003cli data-start=\"3301\" data-end=\"3470\"\u003e\n\u003cstrong data-start=\"3303\" data-end=\"3322\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"3327\" data-end=\"3470\"\u003e\r\n\u003cli data-start=\"3327\" data-end=\"3392\"\u003eUse the Ellipta inhaler once daily at the same time each day.\u003c\/li\u003e\r\n\u003cli data-start=\"3395\" data-end=\"3470\"\u003eRinse your mouth after inhalation to reduce the risk of oral candidiasis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3472\" data-end=\"3533\"\u003e\u003cem data-start=\"3472\" data-end=\"3533\"\u003eReference: U.S. FDA; ClinicalTrials.gov (e.g., NCT02222720)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3535\" data-end=\"3538\"\u003e\r\n\u003ch3 data-start=\"3540\" data-end=\"3608\"\u003eWhat prescribing information is important for Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"3609\" data-end=\"4351\"\u003e\r\n\u003cli data-start=\"3609\" data-end=\"3721\"\u003e\n\u003cstrong data-start=\"3611\" data-end=\"3627\"\u003eIndications:\u003c\/strong\u003e Approved for maintenance treatment in patients with COPD (and in some regions, for asthma).\u003c\/li\u003e\r\n\u003cli data-start=\"3722\" data-end=\"3937\"\u003e\n\u003cstrong data-start=\"3724\" data-end=\"3746\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3751\" data-end=\"3937\"\u003e\r\n\u003cli data-start=\"3751\" data-end=\"3836\"\u003eNot for use in patients with acute episodes of bronchospasm or as rescue therapy.\u003c\/li\u003e\r\n\u003cli data-start=\"3839\" data-end=\"3937\"\u003eContraindicated in patients with a known hypersensitivity to any component of the formulation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3938\" data-end=\"4202\"\u003e\n\u003cstrong data-start=\"3940\" data-end=\"3955\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3960\" data-end=\"4202\"\u003e\r\n\u003cli data-start=\"3960\" data-end=\"4035\"\u003eRegular assessment of lung function and symptom control is recommended.\u003c\/li\u003e\r\n\u003cli data-start=\"4038\" data-end=\"4202\"\u003ePeriodic monitoring for potential side effects such as pneumonia or adrenal suppression is advised, especially in patients with a history of recurrent infections.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4203\" data-end=\"4351\"\u003e\n\u003cstrong data-start=\"4205\" data-end=\"4232\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"4237\" data-end=\"4351\"\u003e\r\n\u003cli data-start=\"4237\" data-end=\"4297\"\u003ePatients should be educated on proper inhaler technique.\u003c\/li\u003e\r\n\u003cli data-start=\"4300\" data-end=\"4351\"\u003eIt is not for immediate relief of acute symptoms.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4353\" data-end=\"4454\"\u003e\u003cem data-start=\"4353\" data-end=\"4454\"\u003eReference: U.S. FDA prescribing information; National Institutes of Health (NIH) clinical resources\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4456\" data-end=\"4459\"\u003e\r\n\u003ch3 data-start=\"4461\" data-end=\"4551\"\u003eWhat safety information, warnings, and cautions are associated with Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"4552\" data-end=\"5402\"\u003e\r\n\u003cli data-start=\"4552\" data-end=\"4697\"\u003e\n\u003cstrong data-start=\"4554\" data-end=\"4578\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4583\" data-end=\"4697\"\u003e\r\n\u003cli data-start=\"4583\" data-end=\"4612\"\u003eThrush (oral candidiasis)\u003c\/li\u003e\r\n\u003cli data-start=\"4615\" data-end=\"4629\"\u003eHoarseness\u003c\/li\u003e\r\n\u003cli data-start=\"4632\" data-end=\"4670\"\u003eUpper respiratory tract infections\u003c\/li\u003e\r\n\u003cli data-start=\"4673\" data-end=\"4685\"\u003eHeadache\u003c\/li\u003e\r\n\u003cli data-start=\"4688\" data-end=\"4697\"\u003eCough\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4698\" data-end=\"5148\"\u003e\n\u003cstrong data-start=\"4700\" data-end=\"4724\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4729\" data-end=\"5148\"\u003e\r\n\u003cli data-start=\"4729\" data-end=\"4829\"\u003e\n\u003cstrong data-start=\"4731\" data-end=\"4750\"\u003ePneumonia Risk:\u003c\/strong\u003e Inhaled corticosteroids can increase the risk of pneumonia in COPD patients.\u003c\/li\u003e\r\n\u003cli data-start=\"4832\" data-end=\"4936\"\u003e\n\u003cstrong data-start=\"4834\" data-end=\"4858\"\u003eAdrenal Suppression:\u003c\/strong\u003e Long-term ICS use may suppress adrenal function; monitor if symptoms arise.\u003c\/li\u003e\r\n\u003cli data-start=\"4939\" data-end=\"5035\"\u003e\n\u003cstrong data-start=\"4941\" data-end=\"4959\"\u003eLocal Effects:\u003c\/strong\u003e Rinse mouth after use to minimize local side effects such as oral thrush.\u003c\/li\u003e\r\n\u003cli data-start=\"5038\" data-end=\"5148\"\u003e\n\u003cstrong data-start=\"5040\" data-end=\"5061\"\u003eSystemic Effects:\u003c\/strong\u003e Although the systemic absorption is low, monitor for potential cardiovascular effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5149\" data-end=\"5402\"\u003e\n\u003cstrong data-start=\"5151\" data-end=\"5173\"\u003eDrug Interactions:\u003c\/strong\u003e\r\n\u003cul data-start=\"5178\" data-end=\"5402\"\u003e\r\n\u003cli data-start=\"5178\" data-end=\"5252\"\u003e\n\u003cstrong data-start=\"5180\" data-end=\"5198\"\u003eBeta‑Blockers:\u003c\/strong\u003e May reduce the bronchodilator effect of vilanterol.\u003c\/li\u003e\r\n\u003cli data-start=\"5255\" data-end=\"5402\"\u003e\n\u003cstrong data-start=\"5257\" data-end=\"5291\"\u003eOther Respiratory Medications:\u003c\/strong\u003e Concomitant use with other inhaled therapies should be managed to avoid duplicative effects or adverse events.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5404\" data-end=\"5489\"\u003e\u003cem data-start=\"5404\" data-end=\"5489\"\u003eReference: U.S. FDA; American Thoracic Society (ATS) guidelines; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5491\" data-end=\"5494\"\u003e\r\n\u003ch3 data-start=\"5496\" data-end=\"5567\"\u003eWhat drug interactions should be considered with Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"5568\" data-end=\"5982\"\u003e\r\n\u003cli data-start=\"5568\" data-end=\"5683\"\u003e\n\u003cstrong data-start=\"5570\" data-end=\"5588\"\u003eBeta‑Blockers:\u003c\/strong\u003e Non‑selective beta‑blockers may diminish the bronchodilator response provided by vilanterol.\u003c\/li\u003e\r\n\u003cli data-start=\"5684\" data-end=\"5818\"\u003e\n\u003cstrong data-start=\"5686\" data-end=\"5716\"\u003eOther Inhaled Medications:\u003c\/strong\u003e Use caution when combining with other long‑acting bronchodilators to prevent additive side effects.\u003c\/li\u003e\r\n\u003cli data-start=\"5819\" data-end=\"5982\"\u003e\n\u003cstrong data-start=\"5821\" data-end=\"5850\"\u003eSystemic Corticosteroids:\u003c\/strong\u003e Caution is advised if additional systemic corticosteroid therapy is needed, as this may increase the risk of systemic side effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5984\" data-end=\"6062\"\u003e\u003cem data-start=\"5984\" data-end=\"6062\"\u003eReference: U.S. FDA; National Institutes of Health (NIH) clinical guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6064\" data-end=\"6067\"\u003e\r\n\u003ch3 data-start=\"6069\" data-end=\"6168\"\u003eWhere can I find additional clinical evidence and detailed information about Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"6169\" data-end=\"6267\"\u003eFor more detailed clinical data, dosing guidelines, and safety monitoring information, refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"6268\" data-end=\"6667\"\u003e\r\n\u003cli data-start=\"6268\" data-end=\"6356\"\u003e\n\u003cstrong data-start=\"6270\" data-end=\"6322\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"6323\" data-end=\"6354\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"6357\" data-end=\"6448\"\u003e\n\u003cstrong data-start=\"6359\" data-end=\"6382\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for trials involving Trelegy Ellipta (e.g., NCT02164513)\u003c\/li\u003e\r\n\u003cli data-start=\"6449\" data-end=\"6580\"\u003e\n\u003cstrong data-start=\"6451\" data-end=\"6526\"\u003eNew England Journal of Medicine (NEJM) and Lancet Respiratory Medicine:\u003c\/strong\u003e For peer‑reviewed studies on triple therapy in COPD\u003c\/li\u003e\r\n\u003cli data-start=\"6581\" data-end=\"6667\"\u003e\n\u003cstrong data-start=\"6583\" data-end=\"6630\"\u003eAmerican Thoracic Society (ATS) Guidelines:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.thoracic.org\/\" target=\"_new\" rel=\"noopener\" data-start=\"6631\" data-end=\"6667\"\u003eATS.org\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr data-start=\"6669\" data-end=\"6672\"\u003e\r\n\u003ch3 data-start=\"6674\" data-end=\"6694\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"6695\" data-end=\"7350\"\u003e\u003cstrong data-start=\"6695\" data-end=\"6714\"\u003eTrelegy Ellipta\u003c\/strong\u003e represents a significant advancement in the management of chronic obstructive pulmonary disease (and, in some regions, asthma) by combining three complementary mechanisms of action in a single, once‑daily inhaler. Through the anti‑inflammatory effects of fluticasone furoate, the bronchodilatory action of vilanterol, and the anticholinergic effects of umeclidinium, Trelegy Ellipta improves lung function, reduces exacerbations, and enhances quality of life for patients with COPD. Given the potential risks—such as pneumonia and adrenal suppression—its use should be carefully monitored, and proper inhaler technique must be ensured.\u003c\/p\u003e\r\n\u003cp data-start=\"7352\" data-end=\"7576\"\u003e\u003cem data-start=\"7352\" data-end=\"7576\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"100mcg\/62.5mcg\/25mcg","offer_id":51735706272027,"sku":"Trelegy Ellipta Powder for inhalation (100mcg\/62.5mcg\/25mcg)","price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/trelegy_ellipta_100_62.5_25_mcg_inhalation_powd006f1271-0614-4464-a9a6-aa5c00a021ce.gif?v=1770407365"},{"product_id":"anoro-ellipta","title":"Anoro Ellipta","description":"\u003cdiv class=\"flex-1 overflow-hidden @container\/thread translate-y-[2rem] -mt-[2rem] pb-[1.5rem]\"\u003e\r\n\u003cdiv class=\"flex h-full flex-col overflow-y-auto\"\u003e\r\n\u003cdiv class=\"flex flex-col text-sm md:pb-9\"\u003e\r\n\u003carticle class=\"w-full text-token-text-primary focus-visible:outline-2 focus-visible:outline-offset-[-4px]\" dir=\"auto\" data-testid=\"conversation-turn-63\" data-scroll-anchor=\"true\"\u003e\r\n\u003cdiv class=\"m-auto text-base py-[18px] px-6\"\u003e\r\n\u003cdiv class=\"mx-auto flex flex-1 text-base gap-4 md:gap-5 lg:gap-6 md:max-w-3xl lg:max-w-[40rem] xl:max-w-[48rem]\"\u003e\r\n\u003cdiv class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn @xs\/thread:px-0 @sm\/thread:px-1.5 @md\/thread:px-4\"\u003e\r\n\u003cdiv class=\"flex-col gap-1 md:gap-3\"\u003e\r\n\u003cdiv class=\"flex max-w-full flex-col flex-grow\"\u003e\r\n\u003cdiv class=\"min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words text-start [.text-message+\u0026amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"492a9849-5c54-4c80-9834-5934994743e1\" data-message-model-slug=\"o3-mini\"\u003e\r\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\"\u003e\r\n\u003cdiv class=\"markdown prose w-full break-words dark:prose-invert light\"\u003e\r\n\u003ch3 data-start=\"234\" data-end=\"262\"\u003eWhat is Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"263\" data-end=\"476\"\u003e\u003cstrong data-start=\"263\" data-end=\"280\"\u003eAnoro Ellipta\u003c\/strong\u003e is a once‑daily inhalation medication approved for the long‑term maintenance treatment of chronic obstructive pulmonary disease (COPD). It is a fixed‑dose combination of two active ingredients:\u003c\/p\u003e\r\n\u003cul data-start=\"477\" data-end=\"741\"\u003e\r\n\u003cli data-start=\"477\" data-end=\"613\"\u003e\n\u003cstrong data-start=\"479\" data-end=\"495\"\u003eUmeclidinium\u003c\/strong\u003e, a long‑acting muscarinic antagonist (LAMA) that helps relax airway smooth muscle by blocking muscarinic receptors.\u003c\/li\u003e\r\n\u003cli data-start=\"614\" data-end=\"741\"\u003e\n\u003cstrong data-start=\"616\" data-end=\"630\"\u003eVilanterol\u003c\/strong\u003e, a long‑acting beta₂‑adrenergic agonist (LABA) that promotes bronchodilation by stimulating beta₂‑receptors.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"743\" data-end=\"855\"\u003eTogether, these agents improve lung function, reduce symptoms, and decrease the frequency of COPD exacerbations.\u003c\/p\u003e\r\n\u003cp data-start=\"857\" data-end=\"997\"\u003e\u003cem data-start=\"857\" data-end=\"997\"\u003eReference: U.S. Food and Drug Administration (FDA) prescribing information; ClinicalTrials.gov; American Thoracic Society (ATS) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"999\" data-end=\"1002\"\u003e\r\n\u003ch3 data-start=\"1004\" data-end=\"1061\"\u003eWhat are the other popular names for Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1062\" data-end=\"1289\"\u003eAnoro Ellipta is primarily known by its brand name \u003cstrong data-start=\"1113\" data-end=\"1130\"\u003eAnoro Ellipta\u003c\/strong\u003e. It is also commonly referred to by its generic components, \u003cstrong data-start=\"1191\" data-end=\"1218\"\u003eumeclidinium\/vilanterol\u003c\/strong\u003e, or simply as the \"Anoro inhaler\" in clinical practice and literature.\u003c\/p\u003e\r\n\u003cp data-start=\"1291\" data-end=\"1359\"\u003e\u003cem data-start=\"1291\" data-end=\"1359\"\u003eReference: U.S. FDA; National Institutes of Health (NIH) resources\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1361\" data-end=\"1364\"\u003e\r\n\u003ch3 data-start=\"1366\" data-end=\"1421\"\u003eWhat is the drug classification of Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1422\" data-end=\"1720\"\u003eAnoro Ellipta is classified as a \u003cstrong data-start=\"1455\" data-end=\"1486\"\u003ecombination inhaled therapy\u003c\/strong\u003e for respiratory diseases, specifically within the category of \u003cstrong data-start=\"1549\" data-end=\"1589\"\u003edual bronchodilator therapy for COPD\u003c\/strong\u003e. It belongs to the LAMA\/LABA class, which is widely recommended for improving airflow and reducing exacerbations in COPD patients.\u003c\/p\u003e\r\n\u003cp data-start=\"1722\" data-end=\"1850\"\u003e\u003cem data-start=\"1722\" data-end=\"1850\"\u003eReference: U.S. FDA; Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines; American Thoracic Society (ATS)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1852\" data-end=\"1855\"\u003e\r\n\u003ch3 data-start=\"1857\" data-end=\"1907\"\u003eWhat is the mode of action of Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1908\" data-end=\"1957\"\u003eAnoro Ellipta employs a dual mechanism of action:\u003c\/p\u003e\r\n\u003cul data-start=\"1958\" data-end=\"2239\"\u003e\r\n\u003cli data-start=\"1958\" data-end=\"2093\"\u003e\n\u003cstrong data-start=\"1960\" data-end=\"1984\"\u003eUmeclidinium (LAMA):\u003c\/strong\u003e Inhibits muscarinic receptors in the airway smooth muscle, reducing bronchoconstriction and mucus secretion.\u003c\/li\u003e\r\n\u003cli data-start=\"2094\" data-end=\"2236\"\u003e\n\u003cstrong data-start=\"2096\" data-end=\"2118\"\u003eVilanterol (LABA):\u003c\/strong\u003e Stimulates beta₂‑adrenergic receptors, leading to relaxation of airway smooth muscles and subsequent bronchodilation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2240\" data-end=\"2378\"\u003eThe synergistic effects of these two agents improve lung ventilation, increase forced expiratory volume, and help alleviate COPD symptoms.\u003c\/p\u003e\r\n\u003cp data-start=\"2380\" data-end=\"2485\"\u003e\u003cem data-start=\"2380\" data-end=\"2485\"\u003eReference: New England Journal of Medicine (NEJM) publications on dual bronchodilator therapy; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2487\" data-end=\"2490\"\u003e\r\n\u003ch3 data-start=\"2492\" data-end=\"2524\"\u003eHow is Anoro Ellipta used?\u003c\/h3\u003e\r\n\u003cp data-start=\"2525\" data-end=\"2833\"\u003eAnoro Ellipta is used as a \u003cstrong data-start=\"2552\" data-end=\"2575\"\u003emaintenance therapy\u003c\/strong\u003e for COPD in adult patients. It is prescribed for those who require long‑term bronchodilation and improved lung function, particularly in patients with moderate to severe COPD. It is not intended for the relief of acute bronchospasm or for asthma management.\u003c\/p\u003e\r\n\u003cp data-start=\"2835\" data-end=\"2900\"\u003e\u003cem data-start=\"2835\" data-end=\"2900\"\u003eReference: American Thoracic Society (ATS) guidelines; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2902\" data-end=\"2905\"\u003e\r\n\u003ch3 data-start=\"2907\" data-end=\"2981\"\u003eWhat is the recommended dosage and administration for Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"2982\" data-end=\"3502\"\u003e\r\n\u003cli data-start=\"2982\" data-end=\"3234\"\u003e\n\u003cstrong data-start=\"2984\" data-end=\"2995\"\u003eDosage:\u003c\/strong\u003e The standard dose is \u003cstrong data-start=\"3017\" data-end=\"3046\"\u003eone inhalation once daily\u003c\/strong\u003e from the Ellipta device. Each inhalation typically delivers a fixed dose of approximately 62.5 mcg of umeclidinium and 25 mcg of vilanterol (doses may vary based on regional approvals).\u003c\/li\u003e\r\n\u003cli data-start=\"3235\" data-end=\"3502\"\u003e\n\u003cstrong data-start=\"3237\" data-end=\"3256\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"3261\" data-end=\"3502\"\u003e\r\n\u003cli data-start=\"3261\" data-end=\"3309\"\u003eInhale once daily at the same time each day.\u003c\/li\u003e\r\n\u003cli data-start=\"3312\" data-end=\"3499\"\u003eRinse your mouth after inhalation to reduce the risk of oral thrush (a potential side effect of inhaled corticosteroids used in similar devices, though not applicable to Anoro Ellipta).\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3503\" data-end=\"3596\"\u003e\u003cem data-start=\"3503\" data-end=\"3596\"\u003eReference: U.S. FDA prescribing information; ClinicalTrials.gov (e.g., NCT01691508 studies)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3598\" data-end=\"3601\"\u003e\r\n\u003ch3 data-start=\"3603\" data-end=\"3669\"\u003eWhat prescribing information is important for Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"3670\" data-end=\"4280\"\u003e\r\n\u003cli data-start=\"3670\" data-end=\"3791\"\u003e\n\u003cstrong data-start=\"3672\" data-end=\"3688\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3693\" data-end=\"3791\"\u003e\r\n\u003cli data-start=\"3693\" data-end=\"3791\"\u003eIndicated for the long‑term maintenance treatment of airflow limitation in patients with COPD.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3792\" data-end=\"4051\"\u003e\n\u003cstrong data-start=\"3794\" data-end=\"3816\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3821\" data-end=\"4051\"\u003e\r\n\u003cli data-start=\"3821\" data-end=\"3936\"\u003eNot for use in patients with acute episodes of bronchospasm or for the immediate relief of acute COPD symptoms.\u003c\/li\u003e\r\n\u003cli data-start=\"3939\" data-end=\"4051\"\u003eContraindicated in patients with known hypersensitivity to umeclidinium, vilanterol, or any of the excipients.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4052\" data-end=\"4280\"\u003e\n\u003cstrong data-start=\"4054\" data-end=\"4069\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"4074\" data-end=\"4280\"\u003e\r\n\u003cli data-start=\"4074\" data-end=\"4153\"\u003ePatients should be regularly monitored for symptom control and lung function.\u003c\/li\u003e\r\n\u003cli data-start=\"4156\" data-end=\"4280\"\u003ePeriodic assessment of heart rate and blood pressure is advised, as LABAs can occasionally affect cardiovascular function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4282\" data-end=\"4373\"\u003e\u003cem data-start=\"4282\" data-end=\"4373\"\u003eReference: U.S. FDA; American Thoracic Society (ATS); National Institutes of Health (NIH)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4375\" data-end=\"4378\"\u003e\r\n\u003ch3 data-start=\"4380\" data-end=\"4468\"\u003eWhat safety information, warnings, and cautions are associated with Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"4469\" data-end=\"5129\"\u003e\r\n\u003cli data-start=\"4469\" data-end=\"4552\"\u003e\n\u003cstrong data-start=\"4471\" data-end=\"4495\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4500\" data-end=\"4552\"\u003e\r\n\u003cli data-start=\"4500\" data-end=\"4552\"\u003eDry mouth, cough, headache, and throat irritation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4553\" data-end=\"4923\"\u003e\n\u003cstrong data-start=\"4555\" data-end=\"4579\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4584\" data-end=\"4923\"\u003e\r\n\u003cli data-start=\"4584\" data-end=\"4708\"\u003e\n\u003cstrong data-start=\"4586\" data-end=\"4613\"\u003eCardiovascular Effects:\u003c\/strong\u003e Although generally well-tolerated, LABAs may occasionally cause tachycardia or palpitations.\u003c\/li\u003e\r\n\u003cli data-start=\"4711\" data-end=\"4817\"\u003e\n\u003cstrong data-start=\"4713\" data-end=\"4742\"\u003eParadoxical Bronchospasm:\u003c\/strong\u003e Discontinue use immediately if worsening of respiratory symptoms occurs.\u003c\/li\u003e\r\n\u003cli data-start=\"4820\" data-end=\"4923\"\u003e\n\u003cstrong data-start=\"4822\" data-end=\"4840\"\u003eLocal Effects:\u003c\/strong\u003e Patients should rinse their mouth after use to reduce the risk of oral irritation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4924\" data-end=\"5129\"\u003e\n\u003cstrong data-start=\"4926\" data-end=\"4947\"\u003eSpecial Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4952\" data-end=\"5129\"\u003e\r\n\u003cli data-start=\"4952\" data-end=\"5018\"\u003eUse with caution in patients with severe cardiovascular disease.\u003c\/li\u003e\r\n\u003cli data-start=\"5021\" data-end=\"5129\"\u003eNot recommended for acute symptom relief; a separate short-acting bronchodilator should be used if needed.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5131\" data-end=\"5259\"\u003e\u003cem data-start=\"5131\" data-end=\"5259\"\u003eReference: U.S. FDA; Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines; American Thoracic Society (ATS)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5261\" data-end=\"5264\"\u003e\r\n\u003ch3 data-start=\"5266\" data-end=\"5335\"\u003eWhat drug interactions should be considered with Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"5336\" data-end=\"5830\"\u003e\r\n\u003cli data-start=\"5336\" data-end=\"5537\"\u003e\n\u003cstrong data-start=\"5338\" data-end=\"5364\"\u003eOther Bronchodilators:\u003c\/strong\u003e\r\n\u003cul data-start=\"5369\" data-end=\"5537\"\u003e\r\n\u003cli data-start=\"5369\" data-end=\"5537\"\u003eConcurrent use with other long‑acting bronchodilators may increase the risk of adverse cardiovascular effects; therapy should be managed by a healthcare professional.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5538\" data-end=\"5656\"\u003e\n\u003cstrong data-start=\"5540\" data-end=\"5558\"\u003eBeta‑Blockers:\u003c\/strong\u003e\r\n\u003cul data-start=\"5563\" data-end=\"5656\"\u003e\r\n\u003cli data-start=\"5563\" data-end=\"5656\"\u003eNon‑selective beta‑blockers can potentially reduce the bronchodilator effect of vilanterol.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5657\" data-end=\"5830\"\u003e\n\u003cstrong data-start=\"5659\" data-end=\"5681\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"5686\" data-end=\"5830\"\u003e\r\n\u003cli data-start=\"5686\" data-end=\"5830\"\u003eAlthough the systemic exposure is low, caution is advised when using strong CYP3A4 inhibitors, as they may alter the metabolism of vilanterol.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5832\" data-end=\"5918\"\u003e\u003cem data-start=\"5832\" data-end=\"5918\"\u003eReference: U.S. FDA prescribing information; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5920\" data-end=\"5923\"\u003e\r\n\u003ch3 data-start=\"5925\" data-end=\"6022\"\u003eWhere can I find additional clinical evidence and detailed information about Anoro Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"6023\" data-end=\"6110\"\u003eFor more detailed clinical data, dosing guidelines, and safety information, refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"6111\" data-end=\"6494\"\u003e\r\n\u003cli data-start=\"6111\" data-end=\"6199\"\u003e\n\u003cstrong data-start=\"6113\" data-end=\"6165\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"6166\" data-end=\"6197\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"6200\" data-end=\"6289\"\u003e\n\u003cstrong data-start=\"6202\" data-end=\"6225\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for trials involving Anoro Ellipta (e.g., NCT01691508)\u003c\/li\u003e\r\n\u003cli data-start=\"6290\" data-end=\"6408\"\u003e\n\u003cstrong data-start=\"6292\" data-end=\"6369\"\u003eGlobal Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines:\u003c\/strong\u003e \u003ca href=\"https:\/\/goldcopd.org\/\" target=\"_new\" rel=\"noopener\" data-start=\"6370\" data-end=\"6406\"\u003eGOLD Report\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"6409\" data-end=\"6494\"\u003e\n\u003cstrong data-start=\"6411\" data-end=\"6457\"\u003eAmerican Thoracic Society (ATS) Resources:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.thoracic.org\/\" target=\"_new\" rel=\"noopener\" data-start=\"6458\" data-end=\"6494\"\u003eATS.org\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr data-start=\"6496\" data-end=\"6499\"\u003e\r\n\u003ch3 data-start=\"6501\" data-end=\"6521\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"6522\" data-end=\"7133\"\u003e\u003cstrong data-start=\"6522\" data-end=\"6539\"\u003eAnoro Ellipta\u003c\/strong\u003e provides a convenient, once‑daily dual bronchodilator therapy for patients with COPD. By combining the complementary actions of umeclidinium (a LAMA) and vilanterol (a LABA), it enhances airflow, reduces symptoms, and improves overall lung function. Due to its specific dosing regimen and potential for interactions with other medications (such as beta‑blockers and CYP3A4 inhibitors), it must be used as directed and under the guidance of a healthcare provider. Patients should be well‑instructed on proper inhaler technique to maximize the therapeutic benefits while minimizing side effects.\u003c\/p\u003e\r\n\u003cp data-start=\"7135\" data-end=\"7359\"\u003e\u003cem data-start=\"7135\" data-end=\"7359\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/article\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"EZ Chemist","offers":[{"title":"30 Doses \/ 62.5\/25mcg","offer_id":51735706304795,"sku":"Anoro Ellipta-30 Doses-62.5\/25mcg","price":190.74,"currency_code":"USD","in_stock":true},{"title":"60 Doses \/ 62.5\/25mcg","offer_id":51735706337563,"sku":"Anoro Ellipta-60 Doses-62.5\/25mcg","price":322.74,"currency_code":"USD","in_stock":true},{"title":"90 Doses \/ 62.5\/25mcg","offer_id":51735706370331,"sku":"Anoro Ellipta-90 Doses-62.5\/25mcg","price":413.4,"currency_code":"USD","in_stock":true}]},{"product_id":"rofaday","title":"Rofaday","description":"\u003ch3 data-start=\"343\" data-end=\"369\"\u003eWhat is Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"370\" data-end=\"750\"\u003e\u003cstrong data-start=\"370\" data-end=\"385\"\u003eRoflumilast\u003c\/strong\u003e is an oral, selective phosphodiesterase‑4 (PDE4) inhibitor approved for use as a maintenance treatment in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations. It works by reducing airway inflammation, thereby improving lung function and decreasing the frequency of COPD exacerbations.\u003c\/p\u003e\r\n\u003cp data-start=\"752\" data-end=\"903\"\u003e\u003cem data-start=\"752\" data-end=\"903\"\u003eReference: U.S. Food and Drug Administration (FDA) Roflumilast Prescribing Information; World Health Organization (WHO) guidelines on COPD management\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"905\" data-end=\"908\"\u003e\r\n\u003ch3 data-start=\"910\" data-end=\"965\"\u003eWhat are the other popular names for Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"966\" data-end=\"1029\"\u003eRoflumilast is marketed under several brand names, including:\u003c\/p\u003e\r\n\u003cul data-start=\"1030\" data-end=\"1130\"\u003e\r\n\u003cli data-start=\"1030\" data-end=\"1082\"\u003e\n\u003cstrong data-start=\"1032\" data-end=\"1045\"\u003eDaliresp®\u003c\/strong\u003e (widely used in the United States)\u003c\/li\u003e\r\n\u003cli data-start=\"1083\" data-end=\"1130\"\u003e\n\u003cstrong data-start=\"1085\" data-end=\"1096\"\u003eAriflo®\u003c\/strong\u003e (in some international markets)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"1132\" data-end=\"1173\"\u003e\u003cem data-start=\"1132\" data-end=\"1173\"\u003eReference: U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1175\" data-end=\"1178\"\u003e\r\n\u003ch3 data-start=\"1180\" data-end=\"1233\"\u003eWhat is the drug classification of Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1234\" data-end=\"1443\"\u003eRoflumilast is classified as an \u003cstrong data-start=\"1266\" data-end=\"1299\"\u003eoral selective PDE4 inhibitor\u003c\/strong\u003e. It falls under the therapeutic category of \u003cstrong data-start=\"1344\" data-end=\"1397\"\u003eanti-inflammatory agents for respiratory diseases\u003c\/strong\u003e, specifically used in the management of COPD.\u003c\/p\u003e\r\n\u003cp data-start=\"1445\" data-end=\"1499\"\u003e\u003cem data-start=\"1445\" data-end=\"1499\"\u003eReference: U.S. FDA; World Health Organization (WHO)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1501\" data-end=\"1504\"\u003e\r\n\u003ch3 data-start=\"1506\" data-end=\"1554\"\u003eWhat is the mode of action of Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1555\" data-end=\"1751\"\u003eRoflumilast works by inhibiting the enzyme phosphodiesterase‑4 (PDE4) in inflammatory cells. This inhibition increases intracellular cyclic adenosine monophosphate (cAMP) levels, which leads to:\u003c\/p\u003e\r\n\u003cul data-start=\"1752\" data-end=\"1987\"\u003e\r\n\u003cli data-start=\"1752\" data-end=\"1868\"\u003e\n\u003cstrong data-start=\"1754\" data-end=\"1804\"\u003eReduced Release of Pro-inflammatory Mediators:\u003c\/strong\u003e Lowering cytokine production and inflammation in the airways.\u003c\/li\u003e\r\n\u003cli data-start=\"1869\" data-end=\"1987\"\u003e\n\u003cstrong data-start=\"1871\" data-end=\"1892\"\u003eImproved Airflow:\u003c\/strong\u003e By reducing inflammation, it helps alleviate bronchoconstriction and improves lung function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"1989\" data-end=\"2061\"\u003e\u003cem data-start=\"1989\" data-end=\"2061\"\u003eReference: PubMed (e.g., studies on PDE4 inhibition in COPD); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2063\" data-end=\"2066\"\u003e\r\n\u003ch3 data-start=\"2068\" data-end=\"2098\"\u003eHow is Roflumilast used?\u003c\/h3\u003e\r\n\u003cp data-start=\"2099\" data-end=\"2405\"\u003eRoflumilast is used as a \u003cstrong data-start=\"2124\" data-end=\"2149\"\u003emaintenance treatment\u003c\/strong\u003e in patients with severe COPD, particularly in those with chronic bronchitis who are prone to frequent exacerbations. It is intended for long‑term use as part of a comprehensive treatment plan that may also include bronchodilators and other COPD therapies.\u003c\/p\u003e\r\n\u003cp data-start=\"2407\" data-end=\"2492\"\u003e\u003cem data-start=\"2407\" data-end=\"2492\"\u003eReference: American Thoracic Society (ATS) guidelines; U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2494\" data-end=\"2497\"\u003e\r\n\u003ch3 data-start=\"2499\" data-end=\"2571\"\u003eWhat is the recommended dosage and administration for Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"2572\" data-end=\"2886\"\u003e\r\n\u003cli data-start=\"2572\" data-end=\"2647\"\u003e\n\u003cstrong data-start=\"2574\" data-end=\"2585\"\u003eDosage:\u003c\/strong\u003e The typical recommended oral dose is \u003cstrong data-start=\"2623\" data-end=\"2644\"\u003e500 µg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2648\" data-end=\"2886\"\u003e\n\u003cstrong data-start=\"2650\" data-end=\"2669\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2674\" data-end=\"2886\"\u003e\r\n\u003cli data-start=\"2674\" data-end=\"2777\"\u003eRoflumilast should be taken once daily, with or without food, preferably at the same time each day.\u003c\/li\u003e\r\n\u003cli data-start=\"2780\" data-end=\"2886\"\u003eConsistent use is key to maintaining its anti‑inflammatory effect and improving lung function over time.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2888\" data-end=\"2965\"\u003e\u003cem data-start=\"2888\" data-end=\"2965\"\u003eReference: U.S. FDA Roflumilast Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2967\" data-end=\"2970\"\u003e\r\n\u003ch3 data-start=\"2972\" data-end=\"3036\"\u003eWhat prescribing information is important for Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3037\" data-end=\"3730\"\u003e\r\n\u003cli data-start=\"3037\" data-end=\"3197\"\u003e\n\u003cstrong data-start=\"3039\" data-end=\"3055\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3060\" data-end=\"3197\"\u003e\r\n\u003cli data-start=\"3060\" data-end=\"3197\"\u003eRoflumilast is indicated for reducing the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3198\" data-end=\"3408\"\u003e\n\u003cstrong data-start=\"3200\" data-end=\"3222\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3227\" data-end=\"3408\"\u003e\r\n\u003cli data-start=\"3227\" data-end=\"3294\"\u003eKnown hypersensitivity to roflumilast or any of its components.\u003c\/li\u003e\r\n\u003cli data-start=\"3297\" data-end=\"3408\"\u003eNot recommended for use in patients with moderate to severe liver impairment without careful consideration.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3409\" data-end=\"3539\"\u003e\n\u003cstrong data-start=\"3411\" data-end=\"3426\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3431\" data-end=\"3539\"\u003e\r\n\u003cli data-start=\"3431\" data-end=\"3539\"\u003ePatients should have periodic liver function tests and assessments for potential psychiatric side effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3540\" data-end=\"3730\"\u003e\n\u003cstrong data-start=\"3542\" data-end=\"3569\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3574\" data-end=\"3730\"\u003e\r\n\u003cli data-start=\"3574\" data-end=\"3653\"\u003eRoflumilast should be used as part of a comprehensive COPD management plan.\u003c\/li\u003e\r\n\u003cli data-start=\"3656\" data-end=\"3730\"\u003eThe drug is not intended for the immediate relief of acute bronchospasm.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3732\" data-end=\"3806\"\u003e\u003cem data-start=\"3732\" data-end=\"3806\"\u003eReference: U.S. FDA; WHO; National Institutes of Health (NIH) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3808\" data-end=\"3811\"\u003e\r\n\u003ch3 data-start=\"3813\" data-end=\"3899\"\u003eWhat safety information, warnings, and cautions are associated with Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3900\" data-end=\"4672\"\u003e\r\n\u003cli data-start=\"3900\" data-end=\"3987\"\u003e\n\u003cstrong data-start=\"3902\" data-end=\"3926\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3931\" data-end=\"3987\"\u003e\r\n\u003cli data-start=\"3931\" data-end=\"3987\"\u003eDiarrhea, weight loss, nausea, headache, and insomnia.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3988\" data-end=\"4672\"\u003e\n\u003cstrong data-start=\"3990\" data-end=\"4014\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4019\" data-end=\"4672\"\u003e\r\n\u003cli data-start=\"4019\" data-end=\"4180\"\u003e\n\u003cstrong data-start=\"4021\" data-end=\"4045\"\u003ePsychiatric Effects:\u003c\/strong\u003e Roflumilast may be associated with mood changes, anxiety, or depression in some patients. Monitor for signs of psychiatric distress.\u003c\/li\u003e\r\n\u003cli data-start=\"4183\" data-end=\"4323\"\u003e\n\u003cstrong data-start=\"4185\" data-end=\"4214\"\u003eGastrointestinal Effects:\u003c\/strong\u003e Diarrhea and weight loss can occur; patients should be advised to maintain proper hydration and nutrition.\u003c\/li\u003e\r\n\u003cli data-start=\"4326\" data-end=\"4501\"\u003e\n\u003cstrong data-start=\"4328\" data-end=\"4349\"\u003eHepatic Function:\u003c\/strong\u003e There is a risk of liver enzyme elevation; liver function should be monitored periodically, especially in patients with preexisting liver conditions.\u003c\/li\u003e\r\n\u003cli data-start=\"4504\" data-end=\"4672\"\u003e\n\u003cstrong data-start=\"4506\" data-end=\"4541\"\u003eContraindications in Pregnancy:\u003c\/strong\u003e Roflumilast is contraindicated during pregnancy and lactation. Women of childbearing potential should use effective contraception.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4674\" data-end=\"4774\"\u003e\u003cem data-start=\"4674\" data-end=\"4774\"\u003eReference: U.S. FDA Roflumilast Prescribing Information; PubMed literature on PDE4 inhibitors; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4776\" data-end=\"4779\"\u003e\r\n\u003ch3 data-start=\"4781\" data-end=\"4848\"\u003eWhat drug interactions should be considered with Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"4849\" data-end=\"5364\"\u003e\r\n\u003cli data-start=\"4849\" data-end=\"5067\"\u003e\n\u003cstrong data-start=\"4851\" data-end=\"4873\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"4878\" data-end=\"5067\"\u003e\r\n\u003cli data-start=\"4878\" data-end=\"5067\"\u003eConcomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase plasma levels of roflumilast and its active metabolite, potentially enhancing adverse effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5068\" data-end=\"5222\"\u003e\n\u003cstrong data-start=\"5070\" data-end=\"5122\"\u003eOther Medications with Gastrointestinal Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"5127\" data-end=\"5222\"\u003e\r\n\u003cli data-start=\"5127\" data-end=\"5222\"\u003eDrugs that cause gastrointestinal upset may have additive effects when used with roflumilast.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5223\" data-end=\"5364\"\u003e\n\u003cstrong data-start=\"5225\" data-end=\"5248\"\u003eHepatotoxic Agents:\u003c\/strong\u003e\r\n\u003cul data-start=\"5253\" data-end=\"5364\"\u003e\r\n\u003cli data-start=\"5253\" data-end=\"5364\"\u003eCaution is advised when roflumilast is used in patients receiving medications that can impair liver function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5366\" data-end=\"5428\"\u003e\u003cem data-start=\"5366\" data-end=\"5428\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5430\" data-end=\"5433\"\u003e\r\n\u003ch3 data-start=\"5435\" data-end=\"5530\"\u003eWhere can I find additional clinical evidence and detailed information about Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"5531\" data-end=\"5621\"\u003eFor further details on clinical studies, dosing, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"5622\" data-end=\"5930\"\u003e\r\n\u003cli data-start=\"5622\" data-end=\"5710\"\u003e\n\u003cstrong data-start=\"5624\" data-end=\"5676\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"5677\" data-end=\"5708\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"5711\" data-end=\"5789\"\u003e\n\u003cstrong data-start=\"5713\" data-end=\"5736\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for roflumilast studies (e.g., NCT00910696)\u003c\/li\u003e\r\n\u003cli data-start=\"5790\" data-end=\"5857\"\u003e\n\u003cstrong data-start=\"5792\" data-end=\"5828\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e COPD management guidelines\u003c\/li\u003e\r\n\u003cli data-start=\"5858\" data-end=\"5930\"\u003e\n\u003cstrong data-start=\"5860\" data-end=\"5871\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on roflumilast in COPD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5932\" data-end=\"5966\"\u003e\u003cem data-start=\"5932\" data-end=\"5966\"\u003eReference: U.S. FDA; WHO; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5968\" data-end=\"5971\"\u003e\r\n\u003ch3 data-start=\"5973\" data-end=\"5993\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"5994\" data-end=\"6605\"\u003e\u003cstrong data-start=\"5994\" data-end=\"6009\"\u003eRoflumilast\u003c\/strong\u003e is an effective oral PDE4 inhibitor used to reduce the frequency of COPD exacerbations in patients with severe COPD and chronic bronchitis. By increasing cAMP levels in inflammatory cells, it diminishes airway inflammation and improves lung function. Due to its potential gastrointestinal and psychiatric side effects—and its interactions with certain CYP3A4 inhibitors—roflumilast should be prescribed with careful patient selection and monitoring. Always consult your healthcare provider to determine if roflumilast is the appropriate treatment as part of a comprehensive COPD management plan.\u003c\/p\u003e\r\n\u003cp data-start=\"6607\" data-end=\"6831\"\u003e\u003cem data-start=\"6607\" data-end=\"6831\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"500mcg","offer_id":51735706403099,"sku":"Generic-Deliresp-(Roflumilast)-Rofum-1-1","price":35.4,"currency_code":"USD","in_stock":true}]},{"product_id":"rofum","title":"Rofum","description":"\u003ch3 data-start=\"343\" data-end=\"369\"\u003eWhat is Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"370\" data-end=\"750\"\u003e\u003cstrong data-start=\"370\" data-end=\"385\"\u003eRoflumilast\u003c\/strong\u003e is an oral, selective phosphodiesterase‑4 (PDE4) inhibitor approved for use as a maintenance treatment in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations. It works by reducing airway inflammation, thereby improving lung function and decreasing the frequency of COPD exacerbations.\u003c\/p\u003e\r\n\u003cp data-start=\"752\" data-end=\"903\"\u003e\u003cem data-start=\"752\" data-end=\"903\"\u003eReference: U.S. Food and Drug Administration (FDA) Roflumilast Prescribing Information; World Health Organization (WHO) guidelines on COPD management\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"905\" data-end=\"908\"\u003e\r\n\u003ch3 data-start=\"910\" data-end=\"965\"\u003eWhat are the other popular names for Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"966\" data-end=\"1029\"\u003eRoflumilast is marketed under several brand names, including:\u003c\/p\u003e\r\n\u003cul data-start=\"1030\" data-end=\"1130\"\u003e\r\n\u003cli data-start=\"1030\" data-end=\"1082\"\u003e\n\u003cstrong data-start=\"1032\" data-end=\"1045\"\u003eDaliresp®\u003c\/strong\u003e (widely used in the United States)\u003c\/li\u003e\r\n\u003cli data-start=\"1083\" data-end=\"1130\"\u003e\n\u003cstrong data-start=\"1085\" data-end=\"1096\"\u003eAriflo®\u003c\/strong\u003e (in some international markets)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"1132\" data-end=\"1173\"\u003e\u003cem data-start=\"1132\" data-end=\"1173\"\u003eReference: U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1175\" data-end=\"1178\"\u003e\r\n\u003ch3 data-start=\"1180\" data-end=\"1233\"\u003eWhat is the drug classification of Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1234\" data-end=\"1443\"\u003eRoflumilast is classified as an \u003cstrong data-start=\"1266\" data-end=\"1299\"\u003eoral selective PDE4 inhibitor\u003c\/strong\u003e. It falls under the therapeutic category of \u003cstrong data-start=\"1344\" data-end=\"1397\"\u003eanti-inflammatory agents for respiratory diseases\u003c\/strong\u003e, specifically used in the management of COPD.\u003c\/p\u003e\r\n\u003cp data-start=\"1445\" data-end=\"1499\"\u003e\u003cem data-start=\"1445\" data-end=\"1499\"\u003eReference: U.S. FDA; World Health Organization (WHO)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1501\" data-end=\"1504\"\u003e\r\n\u003ch3 data-start=\"1506\" data-end=\"1554\"\u003eWhat is the mode of action of Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"1555\" data-end=\"1751\"\u003eRoflumilast works by inhibiting the enzyme phosphodiesterase‑4 (PDE4) in inflammatory cells. This inhibition increases intracellular cyclic adenosine monophosphate (cAMP) levels, which leads to:\u003c\/p\u003e\r\n\u003cul data-start=\"1752\" data-end=\"1987\"\u003e\r\n\u003cli data-start=\"1752\" data-end=\"1868\"\u003e\n\u003cstrong data-start=\"1754\" data-end=\"1804\"\u003eReduced Release of Pro-inflammatory Mediators:\u003c\/strong\u003e Lowering cytokine production and inflammation in the airways.\u003c\/li\u003e\r\n\u003cli data-start=\"1869\" data-end=\"1987\"\u003e\n\u003cstrong data-start=\"1871\" data-end=\"1892\"\u003eImproved Airflow:\u003c\/strong\u003e By reducing inflammation, it helps alleviate bronchoconstriction and improves lung function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"1989\" data-end=\"2061\"\u003e\u003cem data-start=\"1989\" data-end=\"2061\"\u003eReference: PubMed (e.g., studies on PDE4 inhibition in COPD); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2063\" data-end=\"2066\"\u003e\r\n\u003ch3 data-start=\"2068\" data-end=\"2098\"\u003eHow is Roflumilast used?\u003c\/h3\u003e\r\n\u003cp data-start=\"2099\" data-end=\"2405\"\u003eRoflumilast is used as a \u003cstrong data-start=\"2124\" data-end=\"2149\"\u003emaintenance treatment\u003c\/strong\u003e in patients with severe COPD, particularly in those with chronic bronchitis who are prone to frequent exacerbations. It is intended for long‑term use as part of a comprehensive treatment plan that may also include bronchodilators and other COPD therapies.\u003c\/p\u003e\r\n\u003cp data-start=\"2407\" data-end=\"2492\"\u003e\u003cem data-start=\"2407\" data-end=\"2492\"\u003eReference: American Thoracic Society (ATS) guidelines; U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2494\" data-end=\"2497\"\u003e\r\n\u003ch3 data-start=\"2499\" data-end=\"2571\"\u003eWhat is the recommended dosage and administration for Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"2572\" data-end=\"2886\"\u003e\r\n\u003cli data-start=\"2572\" data-end=\"2647\"\u003e\n\u003cstrong data-start=\"2574\" data-end=\"2585\"\u003eDosage:\u003c\/strong\u003e The typical recommended oral dose is \u003cstrong data-start=\"2623\" data-end=\"2644\"\u003e500 µg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2648\" data-end=\"2886\"\u003e\n\u003cstrong data-start=\"2650\" data-end=\"2669\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2674\" data-end=\"2886\"\u003e\r\n\u003cli data-start=\"2674\" data-end=\"2777\"\u003eRoflumilast should be taken once daily, with or without food, preferably at the same time each day.\u003c\/li\u003e\r\n\u003cli data-start=\"2780\" data-end=\"2886\"\u003eConsistent use is key to maintaining its anti‑inflammatory effect and improving lung function over time.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2888\" data-end=\"2965\"\u003e\u003cem data-start=\"2888\" data-end=\"2965\"\u003eReference: U.S. FDA Roflumilast Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2967\" data-end=\"2970\"\u003e\r\n\u003ch3 data-start=\"2972\" data-end=\"3036\"\u003eWhat prescribing information is important for Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3037\" data-end=\"3730\"\u003e\r\n\u003cli data-start=\"3037\" data-end=\"3197\"\u003e\n\u003cstrong data-start=\"3039\" data-end=\"3055\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3060\" data-end=\"3197\"\u003e\r\n\u003cli data-start=\"3060\" data-end=\"3197\"\u003eRoflumilast is indicated for reducing the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3198\" data-end=\"3408\"\u003e\n\u003cstrong data-start=\"3200\" data-end=\"3222\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3227\" data-end=\"3408\"\u003e\r\n\u003cli data-start=\"3227\" data-end=\"3294\"\u003eKnown hypersensitivity to roflumilast or any of its components.\u003c\/li\u003e\r\n\u003cli data-start=\"3297\" data-end=\"3408\"\u003eNot recommended for use in patients with moderate to severe liver impairment without careful consideration.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3409\" data-end=\"3539\"\u003e\n\u003cstrong data-start=\"3411\" data-end=\"3426\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3431\" data-end=\"3539\"\u003e\r\n\u003cli data-start=\"3431\" data-end=\"3539\"\u003ePatients should have periodic liver function tests and assessments for potential psychiatric side effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3540\" data-end=\"3730\"\u003e\n\u003cstrong data-start=\"3542\" data-end=\"3569\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3574\" data-end=\"3730\"\u003e\r\n\u003cli data-start=\"3574\" data-end=\"3653\"\u003eRoflumilast should be used as part of a comprehensive COPD management plan.\u003c\/li\u003e\r\n\u003cli data-start=\"3656\" data-end=\"3730\"\u003eThe drug is not intended for the immediate relief of acute bronchospasm.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3732\" data-end=\"3806\"\u003e\u003cem data-start=\"3732\" data-end=\"3806\"\u003eReference: U.S. FDA; WHO; National Institutes of Health (NIH) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3808\" data-end=\"3811\"\u003e\r\n\u003ch3 data-start=\"3813\" data-end=\"3899\"\u003eWhat safety information, warnings, and cautions are associated with Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"3900\" data-end=\"4672\"\u003e\r\n\u003cli data-start=\"3900\" data-end=\"3987\"\u003e\n\u003cstrong data-start=\"3902\" data-end=\"3926\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3931\" data-end=\"3987\"\u003e\r\n\u003cli data-start=\"3931\" data-end=\"3987\"\u003eDiarrhea, weight loss, nausea, headache, and insomnia.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3988\" data-end=\"4672\"\u003e\n\u003cstrong data-start=\"3990\" data-end=\"4014\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4019\" data-end=\"4672\"\u003e\r\n\u003cli data-start=\"4019\" data-end=\"4180\"\u003e\n\u003cstrong data-start=\"4021\" data-end=\"4045\"\u003ePsychiatric Effects:\u003c\/strong\u003e Roflumilast may be associated with mood changes, anxiety, or depression in some patients. Monitor for signs of psychiatric distress.\u003c\/li\u003e\r\n\u003cli data-start=\"4183\" data-end=\"4323\"\u003e\n\u003cstrong data-start=\"4185\" data-end=\"4214\"\u003eGastrointestinal Effects:\u003c\/strong\u003e Diarrhea and weight loss can occur; patients should be advised to maintain proper hydration and nutrition.\u003c\/li\u003e\r\n\u003cli data-start=\"4326\" data-end=\"4501\"\u003e\n\u003cstrong data-start=\"4328\" data-end=\"4349\"\u003eHepatic Function:\u003c\/strong\u003e There is a risk of liver enzyme elevation; liver function should be monitored periodically, especially in patients with preexisting liver conditions.\u003c\/li\u003e\r\n\u003cli data-start=\"4504\" data-end=\"4672\"\u003e\n\u003cstrong data-start=\"4506\" data-end=\"4541\"\u003eContraindications in Pregnancy:\u003c\/strong\u003e Roflumilast is contraindicated during pregnancy and lactation. Women of childbearing potential should use effective contraception.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4674\" data-end=\"4774\"\u003e\u003cem data-start=\"4674\" data-end=\"4774\"\u003eReference: U.S. FDA Roflumilast Prescribing Information; PubMed literature on PDE4 inhibitors; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4776\" data-end=\"4779\"\u003e\r\n\u003ch3 data-start=\"4781\" data-end=\"4848\"\u003eWhat drug interactions should be considered with Roflumilast?\u003c\/h3\u003e\r\n\u003cul data-start=\"4849\" data-end=\"5364\"\u003e\r\n\u003cli data-start=\"4849\" data-end=\"5067\"\u003e\n\u003cstrong data-start=\"4851\" data-end=\"4873\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"4878\" data-end=\"5067\"\u003e\r\n\u003cli data-start=\"4878\" data-end=\"5067\"\u003eConcomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase plasma levels of roflumilast and its active metabolite, potentially enhancing adverse effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5068\" data-end=\"5222\"\u003e\n\u003cstrong data-start=\"5070\" data-end=\"5122\"\u003eOther Medications with Gastrointestinal Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"5127\" data-end=\"5222\"\u003e\r\n\u003cli data-start=\"5127\" data-end=\"5222\"\u003eDrugs that cause gastrointestinal upset may have additive effects when used with roflumilast.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5223\" data-end=\"5364\"\u003e\n\u003cstrong data-start=\"5225\" data-end=\"5248\"\u003eHepatotoxic Agents:\u003c\/strong\u003e\r\n\u003cul data-start=\"5253\" data-end=\"5364\"\u003e\r\n\u003cli data-start=\"5253\" data-end=\"5364\"\u003eCaution is advised when roflumilast is used in patients receiving medications that can impair liver function.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5366\" data-end=\"5428\"\u003e\u003cem data-start=\"5366\" data-end=\"5428\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5430\" data-end=\"5433\"\u003e\r\n\u003ch3 data-start=\"5435\" data-end=\"5530\"\u003eWhere can I find additional clinical evidence and detailed information about Roflumilast?\u003c\/h3\u003e\r\n\u003cp data-start=\"5531\" data-end=\"5621\"\u003eFor further details on clinical studies, dosing, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"5622\" data-end=\"5930\"\u003e\r\n\u003cli data-start=\"5622\" data-end=\"5710\"\u003e\n\u003cstrong data-start=\"5624\" data-end=\"5676\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"5677\" data-end=\"5708\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"5711\" data-end=\"5789\"\u003e\n\u003cstrong data-start=\"5713\" data-end=\"5736\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for roflumilast studies (e.g., NCT00910696)\u003c\/li\u003e\r\n\u003cli data-start=\"5790\" data-end=\"5857\"\u003e\n\u003cstrong data-start=\"5792\" data-end=\"5828\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e COPD management guidelines\u003c\/li\u003e\r\n\u003cli data-start=\"5858\" data-end=\"5930\"\u003e\n\u003cstrong data-start=\"5860\" data-end=\"5871\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on roflumilast in COPD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5932\" data-end=\"5966\"\u003e\u003cem data-start=\"5932\" data-end=\"5966\"\u003eReference: U.S. FDA; WHO; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5968\" data-end=\"5971\"\u003e\r\n\u003ch3 data-start=\"5973\" data-end=\"5993\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"5994\" data-end=\"6605\"\u003e\u003cstrong data-start=\"5994\" data-end=\"6009\"\u003eRoflumilast\u003c\/strong\u003e is an effective oral PDE4 inhibitor used to reduce the frequency of COPD exacerbations in patients with severe COPD and chronic bronchitis. By increasing cAMP levels in inflammatory cells, it diminishes airway inflammation and improves lung function. Due to its potential gastrointestinal and psychiatric side effects—and its interactions with certain CYP3A4 inhibitors—roflumilast should be prescribed with careful patient selection and monitoring. Always consult your healthcare provider to determine if roflumilast is the appropriate treatment as part of a comprehensive COPD management plan.\u003c\/p\u003e\r\n\u003cp data-start=\"6607\" data-end=\"6831\"\u003e\u003cem data-start=\"6607\" data-end=\"6831\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"500mcg","offer_id":51735706468635,"sku":"Generic-Deliresp-(Roflumilast)-Rofum-1-1","price":35.4,"currency_code":"USD","in_stock":true}]}],"url":"https:\/\/ezchemist.com\/collections\/asthma-care.oembed","provider":"EZ Chemist","version":"1.0","type":"link"}